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ABSTRACT 
 
EVALUATION OF THE ROLE OF OXIDATIVE STRESS, INFLAMMATION AND APOPTOSIS IN THE 
PULMONARY AND THE HEPATIC TOXICITY INDUCED BY CERIUM OXIDE NANOPARTICLES 
FOLLOWING INTRATRACHEAL INSTILLATION IN MALE SPRAGUE-DAWLEY RATS 
By 
Siva Krishna Nalabotu 
The field of nanotechnology is rapidly progressing with potential applications in the 
automobile, healthcare, electronics, cosmetics, textiles, information technology, and 
environmental sectors. Nanomaterials are engineered structures with at least one dimension of 
100 nanometers or less.  With increased applications of nanotechnology, there are increased 
chances of exposure to manufactured nanomaterials. Recent reports on the toxicity of 
engineered nanomaterials have given scientific and regulatory agencies concerns over the 
safety of nanomaterials. Specifically, the Organization for Economic Co-operation and 
Development (OECD) has identified fourteen high priority nanomaterials for study. Cerium 
oxide (CeO2) nanoparticles are one among the high priority group. Recent data suggest that 
CeO2 nanoparticles may be toxic to lung cell lines in vitro and lung tissues in vivo. Other work 
has proposed that oxidative stress may play an important role in the toxicity; however, the 
exact mechanism of the toxicity, has to our knowledge, not been investigated. Similarly, it is not 
clear whether CeO2 nanoparticles exhibit systemic toxicity. Here, we investigate whether 
pulmonary exposure to CeO2 nanoparticles is associated with oxidative stress, inflammation 
and apoptosis in the lungs and liver of adult male Sprague-Dawley rats. 
xviii 
 
Our data suggest that the intratracheal instillation of CeO2 nanoparticles can cause an 
increased lung weight to body weight ratio. Changes in lung weights were associated with the 
accumulation of cerium in the lungs, elevations in serum inflammatory markers, an increased 
Bax to Bcl-2 ratio, elevated caspase-3 protein levels, increased phosphorylation of p38-MAPK 
and diminished phosphorylation of ERK1/2-MAPK.   
Our findings from the study evaluating the possible translocation of CeO2 nanoparticles 
from the lungs to the liver suggest that CeO2 nanoparticle exposure was associated with 
increased liver ceria levels, elevations in serum alanine transaminase levels, reduced albumin 
levels, a diminished sodium-potassium ratio and decreased serum triglyceride levels. Consistent 
with these data, rats exposed to CeO2 nanoparticles also exhibited reductions in liver weight 
and dose dependent hydropic degeneration, hepatocyte enlargement, sinusoidal dilatation and 
the accumulation of granular material in the hepatocytes.  
In a follow-up study, we next examined if CeO2 deposition in the liver is characterized by 
increased oxidative stress and apoptosis. Our data demonstrate that increased cerium in the 
liver is associated with increased oxidative stress and apoptosis as assessed from 
hydroethidium staining, the analysis of lipid peroxidation, and TUNEL staining. In addition, 
increased cerium concentration in the liver was associated with an increased Bax to Bcl-2 ratio, 
elevated caspase-9 and elevated caspase-3 protein levels.  
Taken together, these data suggest that exposure to CeO2 nanoparticles is associated 
with increased oxidative stress and cellular apoptosis in the lungs. It is also evident that CeO2 
nanoparticles can translocate to liver and induce hepatic damage. The hepatic damage induced 
by CeO2 nanoparticles is associated with increased oxidative stress and apoptosis in the liver.
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Chapter 1  
Introduction 
Nanotechnology can be defined as the design, synthesis, and application of materials 
and devices whose size and shape have been engineered at the nanoscale (1-100 nm). Particles 
with at least one dimension smaller than 100 nm and potentially as small as atomic and 
molecular length scales (~0.2 nm) are termed nanoparticles [1, 2]. Given a very high surface 
area to volume ratio, nanomaterials have different physical and chemical properties when 
compared with their bulk counterparts and have been proposed to exhibit tremendous 
applications in several sectors [2]. At the nanoscale, quantum effects start to dominate which 
can result in different electric, magnetic and conductive properties than that observed in 
traditional materials [3]. Because of these special properties, nanomaterials have been 
proposed to be of use in the biomedical sector for applications in imaging, diagnosis and as 
therapeutic agents [4]. It is estimated that there are almost 800 nanoproducts available in the 
market that have been manufactured by 322 companies across the world [5].   
With the growing incorporation of nanomaterials into our day to day life, the potential 
for exposure is increasing daily. Whether or not nanomaterials exhibit deleterious effects to 
human life and the ecosystems is not well understood. As such, an evaluation of interaction of 
nanomaterials with biological systems is highly warranted. Of the various types of 
nanomaterials available, the toxicity evaluation of the engineered (manufactured) 
nanoparticles is perhaps the most important as the industrial production of manufactured 
nanomaterials is progressing rapidly. Recent studies reporting the toxicity of engineered 
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nanomaterials have led to concerns by scientific and regulatory agencies about the toxicity of 
engineered nanomaterials. The Organization for Economic Cooperation and Development 
Working Party on Manufactured Nanomaterials (OECD MPMN) has identified fourteen 
manufactured nanomaterials for evaluation. Materials identified include fullerenes, carbon 
nanotubes, metal oxides, nanoclays and CeO2 nanoparticles [6]. At present, data regarding the 
potential toxicity of CeO2 nanoparticles are limited.   
     Cerium is a rare earth metal and is the most reactive lanthanide metal. Cerium can 
exist in Ce3+ and Ce4+ states with Ce4+ being the most stable form. Nanoparticles made from 
cerium oxide (CeO2) have been widely used in fuel cells, solar cells, for polishing of materials, in 
UV blockers and in the automobile industries as well for catalysts [7]. Cerium exhibits a fluorite 
like chemical structure that enables it to donate or receive the oxygen atoms depending on the 
partial pressure of oxygen in the surrounding environment [8]. This property of redox cycling 
makes cerium an efficient agent for reduction and oxidation reactions. At the nanoscale, CeO2 
nanoparticles have increased surface area, expansion of lattice [8], and a higher melting point 
when compared to their bulk counterparts. It is thought that these properties allow CeO2 
nanoparticles to exhibit anti-oxidant activity [9]. Recent studies have shown that CeO2 
nanoparticles can be used to scavenge reactive oxygen species (ROS) and this activity can 
protect against cardiomyopathy [10], oxidative neuronal toxicity [11], and radiation-induced 
tissue damage [12]. It has been proposed that CeO2 nanoparticles may mimic the action of the 
superoxide dismutase (SOD) and catalase enzymes where they function to scavenge reactive 
oxygen species that are generated in the cell [13]. Whether CeO2 nanoparticles exhibit toxic 
effects to cellular function is not well understood. 
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The most common route of exposure to CeO2 nanoparticles is likely to be through 
inhalation or ingestion. The inhalation route is the most worrisome route of the exposure as the 
absorption of CeO2 nanoparticles through ingestion is typically minimal [7]. Although there are 
limited studies on the toxicity of CeO2 nanoparticles, most of these studies are centered on the 
toxicological evaluation on lung cells and lung tissues.  
Studies on microorganisms such as E. coli have shown that CeO2 nanoparticles (7nm) 
can induce cell death and the oxidative stress might be the possible mechanism of toxicity[14]. 
In vitro studies using human bronchoalveolar carcinoma cell line (BEAS-2B) and lung epithelial 
cell lines (A549) demonstrated that exposure to CeO2 nanoparticles (20 nm) is associated with 
reduced cell viability and increased oxidative stress[15]. Conversely, CeO2 nanoparticles were 
not shown to be toxic to T98G (glioblastoma cell line) and H9C2 (cardiomyoblast) cell lines [16] . 
In vivo studies on male Sprague- Dawley rats showed that exposure to CeO2 nanoparticles 
(20nm) can cause lung damage and fibrosis [17]. These changes in the lung structure were 
associated with increased infiltration of inflammatory cells and increased accumulation of 
nanoparticles in the alveolar spaces. This work also demonstrated that CeO2 nanoparticles can 
cause lung damage by increasing oxidative stress causing apoptosis of the lung macrophages. 
Nonetheless, it is not yet mechanistically clear how exposure to CeO2 nanoparticles may induce 
oxidative stress in the intact animal.  
Some studies have proposed that CeO2 nanoparticles can catalyze Fenton-like reactions 
that result in the production of reactive radicals [9]. Other in vitro studies have suggested that 
exposure to CeO2 nanoparticles can diminish the amounts of glutathione and -tocopherol [16] 
while other work has demonstrated that CeO2 nanoparticles can generate ROS in cells[18]. 
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Recent in vitro studies have suggested that the oxidative stress induced by CeO2 nanoparticles 
is mediated through the p38-Nrf-2 signaling pathway [19]. Whether similar cell signaling events 
occur in vivo subsequent to CeO2 nanoparticle exposure has, to our knowledge, not been 
investigated.  
 It is thought that inhaled nanoparticles can translocate to various other organs in the 
body including the liver, kidney, spleen, brain and heart through the systemic circulation[20]. 
Once reaching the cells, other work has demonstrated that nanomaterials can enter the 
nucleus, mitochondria, lipid vesicles and cell membranes and induce toxic effects [21-23]. One 
of the most studied pathways of the nanoparticle mediated toxicity is oxidative stress and 
apoptosis. Nanoparticles have been shown to induce oxidative stress by the production of ROS 
or by decreasing the antioxidant levels in the cell [24].  The oxidative stress is mediated through 
various stress responsive cell signaling events such as activation of the mitogen activated 
protein kinase (MAPK) signaling or through the activation of inflammatory mediators [24]. 
Depending on the magnitude of oxidative stress increase, either apoptosis or necrosis of the 
cell can result. 
CeO2 nanoparticles have shown to translocate to various other organs in the body 
through the systemic circulation [25]. Nonetheless, it is not clear if they induce any toxic effects 
on the liver. Studies on various other metal nanoparticles such as iron oxide, silver, copper and 
gold nanoparticles have shown that they can induce liver toxicity after intratracheal instillation 
[26-28]. As the liver is the major metabolizing organ of the body and a primary source of 
xenobiotic elimination, an examination of the toxicological effects of the CeO2 nanoparticles on 
the liver is warranted. Herein, we propose to evaluate the role of MAPK signaling and caspases 
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in the oxidative stress and apoptosis induced by CeO2 nanoparticles in lungs as well as we 
evaluate if CeO2 nanoparticles exhibit toxic effects on the liver following intratracheal 
instillation.  
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Objectives and Specific Aims 
 Our long-term goal is to evaluate whether CeO2 nanoparticles are toxic to the lungs and 
the liver.  Based on previous studies from the literature using other nanoparticles [2, 17, 24], 
we hypothesize that:  
i. CeO2 nanoparticle accumulation in the lungs will be associated with oxidative stress. The 
oxidative stress induced by CeO2 nanoparticles will activate stress responsive MAPK 
protein signaling and inflammatory protein signaling. Finally, CeO2 nanoparticle- induced 
increases in oxidative stress and inflammation in the lungs will be associated with 
increases in apoptosis. 
ii. Inhaled CeO2 nanoparticles will translocate to liver. 
iii. CeO2 nanoparticle toxicity in the liver will be mediated through oxidative stress and 
apoptosis and will increase with the duration of the exposure to CeO2 nanoparticles. 
Specific Aims 
i. Specific Aim I: To investigate the role of MAPK signaling and inflammatory protein 
signaling in the oxidative stress and apoptosis induced by CeO2 nanoparticles in the 
lungs (Figure 1.1). 
ii. Specific Aim II: To investigate if intratracheal instillation of CeO2 nanoparticles is 
associated with the deposition of ceria in the liver, kidney, spleen and heart of rats. 
iii. Specific Aim III: To investigate if the intratracheal instillation of CeO2 nanoparticles is 
associated with increased hepatic oxidative stress and apoptosis (Figure 1.2) 
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Layouts for the toxicological evaluation studies (Figures 1.1 and 1.2) 
Figure 1-1: Layout of study design for Specific Aim 1 
 
Figure 1-2: Layout of study design for specific aims 2 and 3 
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Chapter 2  
 
2.1 Review of the literature 
The following chapter presents a review of the literature concerning nanotechnology 
and the toxicity of CeO2 nanoparticles. Specifically, we will address the current literature on 
nanotechnology, the unique properties and applications of the nanomaterials, the toxicity of 
the nanomaterials, factors responsible for the nanomaterial toxicity, routes of exposure to 
nanomaterials, cellular uptake and the effects of the nanomaterials on the cell, role of the 
oxidative stress and apoptosis in the toxicity induced by nanoparticles, the structure and unique 
properties of CeO2 nanoparticles and the potential toxicity of CeO2 nanoparticles.   
 
2.2 Introduction to nanotechnology  
The use of nanotechnology is rapidly increasing as industry strives to develop new 
products that are cheaper, better, and less harmful to the environment. It is estimated that 
investments in the nanotechnology industry grew from $13 billion in 2004 to $50 billion in 2006 
and recent data has suggested that this growth will reach $2.6 trillion dollars by 2014 [29, 30]. 
The National Science Foundation has proposed that the worldwide market for nanomaterials 
will reach $1 trillion between 2010 and 2015 [30] with the pharmaceutical industry alone 
contributing approximately $180 billion [31].  
Nanotechnology can be defined as the design, synthesis, and application of materials 
and devices whose size and shape have been engineered at the nanoscale (1-100 nm). 
Materials that have structural components smaller than 100 nm in at least one dimension are 
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referred to as nanomaterials. Particles with at least one dimension smaller than 100 nm and 
potentially as small as atomic and molecular length scales (~0.2 nm) are termed nanoparticles 
[1, 2]. (Figure 2.1: How big are nanomaterials?). There are two types of nanoparticles (NPs): (1) 
naturally occurring NPs (e.g., produced naturally in volcanoes, forest fires or as combustion by-
products) and (2) engineered nanoparticles (ENPs) which have been deliberately developed to 
exhibit some specific property or composition [e.g., carbon black, fumed silica, titanium dioxide 
(TiO2), iron oxide (FeOx), quantum dots (QDs), fullerenes, and carbon nanotubes (CNTs)][1, 2]. 
Figure 2-1: How big are nanomaterials? 
 
Source: http://www.sustainpack.com/nanotechnology.html 
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Recently the Organization for Economic Co-operation and Development (OECD) has 
formed a committee called the Working Party on Manufactured Nanomaterials (WPMN) to 
evaluate more than hundred different types of ENPs available as of today. Work from this effort 
has identified fourteen different ENPs for further evaluation due to their widespread use or 
unusual chemical or physical properties [32, 33] (Table 1).  
Table 1: Engineered nanoparticles chosen by the WPMN for evaluation  
 Fullerenes (C60) 
 Single-walled carbon nanotubes (SWCNTs) 
 Multi-walled carbon nanotubes (MWCNTs) 
 Silver nanoparticles 
 Iron nanoparticles 
 Carbon black 
 Titanium dioxide 
 Aluminium oxide  
 Cerium oxide 
 Zinc oxide 
 Silicon dioxide 
 Polystyrene Dendrimers 
 Nano clays 
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2.3 Unique properties and applications of nanomaterials 
Nanomaterials exhibit unique chemical and physical properties due to their small size 
and increased surface area to volume ratio which allow them to behave differently from their 
bulk counterparts [1, 34]. These unique properties can give rise to increased chemical reactivity 
as well as different optical, electrical and magnetic properties [35]. For example, in its bulk form 
gold is yellow in color; however, gold nanoparticles can be different combinations of red, blue 
or green depending on their size [36, 37] (Figure 2.2).  
Figure 2-2: Effect of size on the optical properties of gold 
 
Source: http://www.ansci.wisc.edu/facstaff/Faculty/pages/albrecht/albrecht_web/Programs/microscopy/colloid.html 
It is estimated that more than 800 products containing some form of nanomaterials are 
being manufactured by 322 companies the world over [38]. Industries utilizing nanomaterials 
include electronics manufacturers (chips, screens), energy (production, catalysis, and storage), 
materials (lubricants, abrasives, paints, tires and sportswear), consumer products (clothes, 
goggles, skin lotions and sun screens), automotive, soil/water remediation (pollution 
absorption, water filtering, and disinfection), pesticides, chemicals and the pharmaceutical 
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sector [1, 2, 30, 39, 40]. Other work is centered on utilizing nanomaterials in food products 
(additives, packaging), medical imaging and as drug delivery systems [41-44]. This development, 
in turn, has led to increasing concerns over the potential ramification of nanomaterial exposure 
to humans and the environment.  
 
2.4 Toxicity of nanomaterials 
 It is thought that the ENPs pose the greatest threat to man and the environment given 
their widespread use and growing importance. Even with the proper precautions it is possible 
for exposure to occur during each phase of the material lifecycle (production, utilization, 
disposal, and recycling) [45]. Potential routes of exposure include inhalation, ingestion, 
absorption through the skin and via the food chain through contamination of food and water 
(Figure 2.3) [7, 46-48].  
 Exposure to nanomaterials is a growing concern. A recent clinical report [49], which was 
the first of its kind, examined seven Chinese women who worked in the paint industry and 
detailed how industrial exposure led to severe respiratory stress and shortness of breath. 
Pathological examination of the worker’s lungs found nonspecific pulmonary inflammation, 
pulmonary fibrosis and foreign-body granulomas of the pleura. Additional transmission electron 
microscopy (TEM) studies confirmed the presence of round polyacrylate nanoparticles ∼30 nm 
in diameter in the cytoplasm, karyoplasm of pulmonary epithelium, mesothelial cells, and in 
chest fluid. Based on these observations, the authors concluded that the long-term exposure to 
polyacrylate nanoparticles could result in serious damage to human lungs.  
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2.5 Factors responsible for the nanomaterial toxicity 
 Nanomaterials display different chemical and electronic properties/reactivity than their 
bulk counterparts [2, 50]. In addition, because of their small size, nanomaterials can easily 
penetrate into subcellular components of the cells where they can cause toxicological effects 
[2, 51, 52]. The shape of the nanomaterials may also play a role in governing potential toxicity 
[53]. In general, nanomaterials with a rod or needle shape are more toxic than the ones with 
round shape. Indeed, recent data has suggested that single walled carbon nanotubes (rods) are 
more toxic than fullerenes (cylindrical) of comparable size. Why shape may influence toxicity is 
not well understood; however, it is likely that shape may mediate, at least in part, particle 
absorption and deposition [54-56]. In addition to size and shape, other work has demonstrated 
that chemical composition along with other physicochemical properties (agglomeration state, 
crystal structure, chemical composition, surface area, and surface chemistry, surface charge, 
etc.) may also influence toxicity [35, 57]. Other studies have shown that the surface properties 
of nanoparticles can influence how they interact with proteins, leading to different types of 
corona and biological effects[58]. 
 
2.6 Respiratory Route of Exposure 
Although nanoparticle exposure can occur via several different routes (respiratory, 
ingestion, dermal and drug delivery), it is thought that the uptake of nanoparticles into the 
body is most likely to occur via the respiratory system [1, 2]. If inhaled, nanomaterials can 
become phagocytized by alveolar macrophages or lodged in the lungs after diffusion through 
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the epithelial cell layer [2]. Upon becoming lodged in the lungs, it is possible for nanomaterials 
to pass across the epithelia of the respiratory track by transcytosis into the interstitium where 
they can enter into the blood either directly or via the lymphatic system [1, 2]. Once within the 
blood, the nanomaterials can then travel to the liver, kidney, spleen heart, brain and bone 
marrow (Figure 2.3) [2, 20, 59, 60]. Research using copper, nickel, gold and manganese oxide 
nanoparticles has shown that nanoparticles can enter into the nervous system through the 
sensory nerve fibers endings that are embedded in the airway epithelia [61-65]. If small 
enough, ENPs can also cross the blood brain barrier [63]. Clearance of the nanoparticles from 
the respiratory system can occur by either physical or chemical processes [1, 2, 66]. The 
physical process of elimination involves mucociliary movement, phagocytosis by macrophages, 
endocytosis into epithelial cells, interstitial translocation and eventual clearance into the blood 
and lymphatic circulation [66]. The chemical process of elimination can occur by protein binding 
or leaching or through the dissolution of the particles or components of the particles that are 
either lipid soluble or soluble in intracellular and extracellular fluids [2]. It is thought that the 
chemical process of elimination appears to be largely dependent upon local extracellular and 
intracellular conditions [67, 68] 
Evaluation of the toxicity of nanomaterials through the respiratory route of exposure in 
animals involves either inhalation of the materials or intratracheal instillation into the lungs. 
Although, the inhalation route provides natural route of entry of the material into the lungs, it 
has several limitations. For example, the inhalation route of exposure needs special facilities, 
while it is also difficult to know with certainty how much of the inhaled material that enters the 
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lungs. As such, it is thought that the intratracheal instillation route is the most preferable 
method to study inhalation toxicity [69].  
Figure 2-3: Potential routes of nanomaterial exposure 
  
Modified from “Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine 
Particles G. Oberdörster et al., Environmental Health Perspectives Volume 113, Number 7, 
2005” 
 
2.7 Cellular effects of engineered nanoparticles  
2.7.1 Cellular uptake of engineered nanoparticles 
Once in the circulation, nanomaterials are taken up into cells by endocytosis 
(phagocytosis or pinocytosis), membrane penetration or passive diffusion through 
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transmembrane channels [2]. The transmembrane passage of nanomaterials is dependent, on 
many factors including the physicochemical properties of the particles (chemical composition, 
size, shape and agglomeration status), cell type (professional phagocytes such as macrophages 
vs. non-professional phagocytes), serum components, and surfactant [1]. After internalization, 
nanomaterials can travel to several different locations within the cell including the outer-cell 
membrane [70], cytoplasm [70], mitochondria [21], lipid vesicles [22], nuclear membrane [71], 
or become lodged within the nucleus itself [23, 72]. If the concentration is high enough, 
nanomaterials can damage cellular organelles and DNA which can result in cell death and, at 
times, disease development (Figure 2.4).   
 
2.8 Mechanisms of nanoparticle toxicity 
Mechanisms of nanoparticle toxicity include oxidative stress, inflammation, genetic 
damage, the inhibition of cell division and cell death [3, 24, 73, 74]. Most work to date has 
suggested that oxidative stress and consequent generation of ROS is a common mechanism of 
nanomaterial toxicity [24, 75]. In vitro studies have shown that TiO2[76] and carbon nanotubes 
[77] all cause toxicity by the generation of ROS. Other work has shown that some nanomaterials 
(e.g. ZnO, SiO2, fullerenes) can generate excited electrons when exposed to light which, in the 
presence of oxygen, can form superoxide radicals by direct electron transfer [78].  
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Figure 2-4: Various effects of the nanomaterials after cellular internalization[1]. 
 
Source: Buzea, Pacheco, and Robbie: Nanomaterials and nanoparticles: Sources and toxicity 
Biointerphases, Vol. 2, No. 4, December 2007 
 
Oxidative stress can be caused either by the depletion of antioxidants or increased 
production of ROS or reactive nitrogen species (RNS). Potential ROS include superoxide anion 
(O2-·), peroxide (O2
-2·), hydroxyl radical (·OH), and singlet oxygen (1O2), an excited form of 
oxygen. Oxygen-derived radicals are generated constantly as part of normal aerobic life. A 
prominent feature of ROS is that they have extremely high chemical reactivity which may help 
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to explain their damaging effects on cells. When produced in excess, ROS can damage proteins, 
lipids and DNA. If the damage is excessive cell death can be induced.  
 
2.8.2 Role of MAP kinases in the nanoparticle induced oxidative stress 
Oxidative stress has been shown to activate stress responsive mitogen-activated protein 
kinases (MAPKs), which are thought to regulate, at least in part, the fate of the cell to go 
through proliferation, differentiation, or cell death [79, 80]. Different studies have shown that 
the suppression of extracellular signal-regulated kinase (ERK1/2-MAPK) and activation of c-Jun 
N-terminal kinase (JNK) and p38 MAPKs play a role in apoptosis in different cell lines [80, 81]. It 
has been revealed that ERK1/2-MAPKs are activated in response to growth factor stimulation 
where they play a very important role in the processes of cellular proliferation and 
differentiation [82, 83]. Conversely, the JNK and p38 MAPKs have been shown to be activated in 
response to cellular stresses such as UV light, osmotic stress, DNA damaging agents and 
proinflammatory cytokines [84, 85] (Figure 2.5). An increased expression of JNK and p38-MAPKs 
has been proposed to cause apoptosis in various cell lines [86]. It has been observed that silver 
nanoparticles can activate JNK protein signaling and apoptosis in a variety of cells [87]. 
Similarly, in vitro studies with CeO2 nanoparticles have shown that they can activate p38 MAPK 
signaling in bronchoalveolar cells [16]. However, the role of MAPKs signaling in nanoparticles 
induced oxidative stress remains largely unknown. 
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Figure 2-5: Modulation of various MAP kinases by stresses to induce varied cellular effects 
 
 
2.8.3 Mechanisms of ROS production and apoptosis 
ROS can be generated directly when both oxidants and free radicals are present on the 
surface of the particles [88-90]. Some nanoparticles have been shown to activate inflammatory 
cells such as the alveolar macrophages and neutrophils which can result in the increased 
production of ROS [90-92]. Other nanomaterials such as TiO2, ZnO, CeO2 and silver 
nanoparticles have been shown to deposit on the cellular surface or inside the subcellular 
organelles and induce oxidative stress signaling cascades that eventually results in the oxidative 
stress to the cell [1]. It appears that the mitochondria are one of the major target organelles for 
nanoparticle-induced oxidative stress [21]. Upon entry into the mitochondria, nanomaterials 
appear to be capable of inducing structural damage which can lead to the impairment of 
20 
 
mitochondrial function [93]. It is well known that high levels of ROS in the mitochondria can 
result in damage to membrane phospholipids which can lead to mitochondrial membrane 
depolarization. In addition, the deposition of nanomaterials in mitochondria can alter normal 
functioning of mitochondria by disrupting the electron transport chain, ultimately resulting in 
the production of ROS. During oxidative phosphorylation, electrons occasionally escape from 
the electron transport chain where they can be accepted by molecular oxygen to form the 
extremely reactive superoxide anion radical (O2-●) which can get further converted to hydrogen 
peroxide (H2O2) or partially reduced to hydroxyl radical (OH
●), one of the strongest oxidants in 
nature [93]. Nanomaterials can increase the rate of superoxide anion production, either by 
blocking the electron transport or by accepting an electron from a respiratory carrier and 
transferring it to molecular oxygen [88, 94]. Mitochondrial damage, if extensive, can trigger 
activation of caspases and cellular apoptosis. 
 
2.8.4 Mitochondrial pathway of apoptosis 
Apart from affecting the cellular proteins, lipids and DNA, ROS have a very crucial role in 
inducing apoptosis in the mitochondria. Conditions of excessive oxidative stress can result in 
the cellular apoptosis or necrosis. Apoptosis has been implicated as a major mechanism of 
cellular death due to nanomaterial-induced toxicity [57, 87, 95, 96]. Among the different 
apoptotic pathways, the mitochondrial pathway seems to play a predominant role. In this 
process, the generation of excessive ROS leads to changes in mitochondrial membrane 
21 
 
potential, an increase in cytochrome C release from the damaged mitochondria and the 
activation of caspase-3.  
The decision to proceed to apoptosis is regulated by the Bcl-2 family of proteins. Bcl-2 
family members can interact with each other or exert function independently and are 
comprised of several different members including those that inhibit (Bcl-2, Bcl-xL, etc.,) or favor 
(Bax, Bak, Bad, etc) apoptosis. Bcl-2 is an anti-apoptotic protein which is predominately present 
in mitochondria. The Bcl-2 protein prevents apoptosis by suppressing oxyradical mediated 
membrane damage and stabilizing mitochondria membrane potential. Conversely, the 
proapoptotic protein Bax can trigger the release of cytochrome C into the cytosol. Once 
released, cytochrome C interacts with APAF-1 and procaspse-9 which results in the formation of 
the apoptosome. The apoptosome then cleaves procaspase-9 into its active form which causes 
the cleavage and activation of the effector caspase, procaspase-3. Once active, caspase-3 then 
initiates cleavage of nuclear and cytosolic proteins resulting in the apoptotic death of the cell 
[94, 97-99]. 
 
2.8.5 Engineered nanoparticles induced inflammation 
Inflammation is the protective mechanism of the organism against adverse reactions 
induced by foreign chemicals or organisms. If limited, inflammation is often times protective in 
nature, but if excessive, inflammation can cause cellular dysfunction. Fullerenes, carbon 
nanotubes, silver nanoparticles and TiO2 nanoparticles have been shown to increase the level of 
inflammatory mediators or cytokines in the circulation which can result in the generation of 
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ROS, hypersensitive reactions, allergic response or granulomas in the target organs [52, 73, 100, 
101]. Nanomaterials have also been shown to activate the nuclear factor kappa B (NF-Kβ) 
transcription factor, which when active, translocates to the nucleus. Once in the nucleus, NF-Kβ 
can induce transcription of the several pro-inflammatory mediators including TNF-alpha, IL-8, 
IL-2 and IL-6 which can lead to increased inflammation and oxidative stress [102, 103].  
Increased production of cytokines can transduce various cell signaling mechanisms. The 
Janus kinase/ signal transducers and activators of transcription (Jak/STAT) pathway is one 
important signaling mechanism that can be transduced by various cytokines [104]. After binding 
of cytokines, the activation of the receptor-associated tyrosine kinases Jak1 and Tyk2 induces 
tyrosine phosphorylation of the receptor subunits and several STAT proteins, which form 
homodimers and/or heterodimers that translocate to the nucleus and regulate the 
transcription of specific target genes that are involved in inflammation [105]. It has been shown 
that STAT proteins can activate p38 MAPK which may play an important role in inflammation 
and apoptosis of the cells [106]. 
 
2.9 Literature review on cerium oxide nanoparticles 
2.9.1 Cerium oxide nanoparticles structure and applications 
Cerium is a lanthanide metal that is also the most reactive rare earth metal. Cerium 
exists in either the Ce4+ or Ce3+ state with the Ce4+ state being the most stable structure. Cerium 
oxide (CeO2) is one of the most stable forms of cerium. There are several synonyms for CeO2 
including cerium oxide, cerium dioxide, ceric oxide and ceria. The fluorite structure, with its 
23 
 
large crystal lattice energy, provides an exceptionally strong stabilizing influence on the CeO2 
[8] (Figure 2.5: Lattice structure of CeO2).  
Figure 2-6: The cubic structure of the cerium dioxide[8] 
 
CeO2 is used in a number of different materials and industrial applications including 
petroleum refineries, solid cell fuel cells, and as polishing materials [7]. CeO2 nanoparticles are 
somewhat unique in that they have the ability to undergo reversible oxygenation / 
deoxygenation cycles based on the partial pressure of the oxygen in the surrounding 
environment [107]. At the nanoscale, CeO2 particles exhibit increased electrical conductivity 
and increased catalytic properties [8].  
CeO2 is widely used as a catalyst and has been incorporated into automobile mufflers to 
reduce toxic engine emissions [108]. CeO2 nanoparticles have been used as an additive to diesel 
fuel since 1999 where they function to reduce particulate emissions as well as to increase fuel 
efficiency [7]. Commercially available cerium based fuel additives include Envirox™ [109], 
Platinum Plus produced by Clean Diesel Technologies Inc. and Eoly DPX-9 (Rhodia) [7]. CeO2 
nanoparticles have also been used in sunscreens as they can absorb UV radiation [110].  
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In addition to their use in industry, CeO2 nanoparticles may also have biomedical 
applications. CeO2 nanoparticles have been shown to be able to scavenge ROS generated in the 
cell and have demonstrated potential application for the treatment of cardiovascular disease, 
neuronal injury and radiation-induced tissue damage in animals [10-12]. How CeO2 
nanoparticles may function to scavenge ROS is not fully understood. Recent work has proposed 
that scavenging of ROS by CeO2 nanoparticles may be due to the ability of CeO2 to cycle back 
and forth between its Ce3+ and Ce4+ states [9, 111]. 
Ce4+ + e-                    Ce3+ 
Ce3+ + OH
. -
              Ce4+ + OH– 
Ce4+ + O2
. -
                   Ce3+ + O2 
Other work has suggested that CeO2 nanoparticles can mimic superoxide dismutase 
(SOD) and catalase [111]. It has also been demonstrated that there is a positive correlation 
between the trivalent oxidation state of CeO2 nanoparticles and superoxide dismutase mimetic 
activity. Additional studies have proposed that surface oxygen vacancies in the CeO2 
nanoparticle may play an indirect role in the radical scavenging properties [112].  
 
2.9.2 Sources of exposure and bio distribution of cerium oxide nanoparticles 
 Potential sources of CeO2 nanoparticles include particles generated by the 
manufacturing industries and diesel exhaust. Recent studies have found that the use of ceria as 
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a diesel fuel additive can result in exhaust emissions containing CeO2 nanoparticles [109].  
Routes of CeO2 nanoparticle exposure include inhalation and ingestion [113].  
Recent work using radiolabeled CeO2 nanoparticles has shown that nearly 80% of the 
inhaled nanoparticles are still present in the lungs at 24 hours [113]. Previous studies with other 
nanomaterials have shown that nanoparticles can be internalized into epithelial cells or 
penetrate into the interstitial space where they can then be taken up into the circulation [2]. 
Studies with CeO2 nanoparticles have shown that the concentration of the cerium in the blood 
is elevated after inhalation and that cerium can accumulate in the liver, kidney, spleen and 
bone [113]. The half-life of cerium elimination has been shown to be 103 days. Approximately 
90% of ingested CeO2 nanoparticles are eliminated through the feces [113]. Thus far, little is 
known about the systemic toxicological effects of CeO2 nanoparticles.  
 
2.9.3 Cerium oxide nanoparticle toxicity 
Recent data suggest that CeO2 nanoparticles are toxic to microorganisms. Thill and 
coworkers demonstrated that large amounts of CeO2 nanoparticles can be adsorbed onto the 
surface of E. coli and that this adsorption can reduce bacterial viability through the generation 
of ROS [14].  
Studies conducted using murine macrophage cells have suggested that the major 
mechanism of CeO2 nanoparticle uptake into the cell is through phagocytosis and diffusion 
through the cell membrane. CeO2 nanoparticles have been shown to localize in cytosol and 
lysosomes [114]. Lin and colleagues studied the toxic effects of 20 nm CeO2 nanoparticles on 
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the lung cancer cell line A549. They demonstrated that exposure to CeO2 nanoparticles is 
associated with reduced cell viability, increased oxidative stress, reduced glutathione, increased 
lipid peroxidation and increased membrane damage [18]. Work by Park and coworkers using 
the human bronchial epithelial cell (BEAS-2B) line showed that exposure to 30 nm CeO2 
nanoparticles is characterized by nanoparticle internalization, increased oxidative stress and 
diminished cell viability in a concentration and time dependent fashion [16]. Additional data 
from their study also demonstrated that CeO2 nanoparticles can induce chromatin 
condensation and cellular apoptosis via the activation of caspase 3.  
 Eom and coworkers studied the possible molecular events associated with the CeO2 
nanoparticle-induced oxidative stress in BEAS-2B cells [19]. This work examined the effect of 
CeO2 nanoparticle exposure on mitogen activated protein kinases (MAPK) signaling and the 
regulation of redox sensitive transcription factors. They demonstrated that exposure to CeO2 
nanoparticles was associated with the activation of caspase 3 and p38 MAPK but not ERK1/2-
MAPK or JNK MAPK signaling. In addition, they also found that the CeO2 nanoparticles can 
induce the translocation of the redox sensitive transcription factor, Nrf-2 into the nucleus and 
the activation of heme oxygenase-1 but not superoxide dismutase or NF-KB. They proposed 
that the activation of HO-1 may be mediated through p38 MAPK signaling.  
 
2.9.4 In vivo toxicity of Cerium Oxide nanoparticles 
Work by Hirst and colleagues showed that the intravenous administration of CeO2 
nanoparticles is associated with increased kidney and liver weights that are dose and time 
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dependent [25]. These researchers also demonstrated the accumulation of cerium in various 
organs. Cerium concentrations were highest in spleen and elevated in the liver and brain. In the 
liver, they noted cerium oxide agglomerates in Kupffer cells and in the hepatocytes [6].  
In vivo studies conducted by Ma and coworkers using rats showed that the inhalation of  
CeO2 nanoparticles causes lung inflammation and alveolar macrophage apoptosis via increased 
oxidative stress [17]. These scientists also found that the CeO2 nanoparticles are taken up by 
alveolar macrophages and that exposure to CeO2 nanoparticles is associated with lung fibrosis. 
He and colleagues studied whether inhaled CeO2 nanoparticles can translocate to other organs 
in the body using rats as a model system [113]. They observed that cerium can undergo extra 
pulmonary translocation where it can accumulate in the liver, spleen, bone, kidney and blood. 
Whether the accumulation of CeO2 nanoparticles was associated with organ dysfunction was 
not addressed.  
 
2.9.5 Possible mechanisms of ROS production by cerium oxide nanoparticles 
CeO2 nanoparticles have been shown to gain entry into the cell through diffusion and 
phagocytosis. Asati and colleagues showed that CeO2 nanoparticles can become localized to the 
lysosome where they can induce cellular toxicity via the up regulation of oxidative stress 
signaling [115]. How CeO2 nanoparticles might cause elevations in oxidative stress is not very 
well understood. Lin and coworkers have proposed that the Ce3+ state produced by the 
reduction of Ce4+ can interact with oxygen molecules to generate superoxide anions [18]. The 
two superoxide anions formed can then interact with each other to form hydrogen peroxide, 
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which then can be converted to hydroxyl radicals (reactions 1-4 below).  It is also possible to 
produce alkoxyl radicals from lipid peroxide (LOOH) (reaction 5). In addition, they also proposed 
that physiologically relevant reductants such as ascorbate and thiol could interact with the CeO2 
nanoparticles and undergo oxidation to produce free radicals and reactive species. 
 
 
Ce4+ + A−red  Ce
3+ + Aox   (1) 
 
Ce3+ + O2  Ce
4+ + O2
−   (2) 
 
O2
−+ O2
−+ 2H+   O2 + H2O2   (3) 
 
H2O2 + Ce
3+   Ce4+ + OH− + OH
·
  (4) 
 
LOOH + Ce3+   Ce4+ + LO
·
 + OH−  (5) 
 
In reaction 1, A− red refer to physiologically relevant reductants, such as ascorbate and thiol 
compounds, whereas Aox are their oxidized states. 
 
3.0 Summary of the review of the literature  
The field of nanotechnology is growing tremendously with applications in various 
industrial sectors including electronics, energy, consumer products, automotive and 
pharmaceutical industries [1, 2, 39]. With the increased application of nanomaterials, there is 
an increased risk of exposure to humans and the ecosystem. The evaluation of nanomaterial 
toxicity is of growing importance. Due to their widespread industrial use, CeO2 nanoparticles 
have been chose by regulatory agencies for toxicology evaluation [7]. Studies conducted with 
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other metallic nanoparticles such as gold, silver, titanium and zinc have shown that the toxicity 
of nanoparticles is characterized by increased oxidative stress and cellular apoptosis [28, 116, 
117]. Whether exposure to CeO2 nanoparticles is associated with similar changes in the lung 
and liver is currently not clear.  
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Chapter 3  
The following chapter includes three different research papers describing in detail the research 
experiments conducted to test our hypotheses set forth for the specific aims I, II and III of this 
dissertation project 
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PAPER I 
Specific Aim 1: To investigate the role of stress responsive MAPKs and inflammatory protein 
signaling in the oxidative stress and apoptosis induced by CeO2 nanoparticles in the lungs 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Exposure to cerium oxide nanoparticles is associated with activation of MAPK signaling and 
apoptosis in the rat lung  
 
Abstract 
Whether exposure to cerium oxide (CeO2) nanoparticles is associated with increased 
oxidative stress and apoptosis in rat lung has not been investigated. Specific pathogen free 
male Sprague-Dawley rats were instilled with either vehicle (saline) or CeO2 nanoparticles at 7.0 
mg/kg and euthanized 1, 3, 14, 28, 56 or 90 days post exposure. Lung tissues were collected 
and evaluated for evidence of oxidative stress and cellular apoptosis. Compared to age-
matched control animals, exposure to CeO2 nanoparticles increased lung weight to body weight 
ratio by ~8%, 34%, 15%, 36%, 80% and 69% at 1, 3, 14, 28, 56 and 90 days post exposure, 
respectively (P<0.05). Changes in lung weight were associated with the cerium accumulation in 
the lungs, elevations in serum inflammatory markers, an increased Bax to Bcl-2 ratio, elevated 
caspase-3 protein levels, increased phosphorylation of p38-MAPK and diminished 
phosphorylation of ERK1/2-MAPK (P<0.05).  Taken together, these data suggest that exposure 
to CeO2 nanoparticles is associated with lung remodeling, oxidative stress and cellular 
apoptosis.  
 
 
Keywords: Cerium Oxide nanoparticles, lung, accumulation, MAP kinases, oxidative stress and 
apoptosis. 
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Introduction 
Cerium is a lanthanide metal that can undergo redox cycling depending on the partial 
pressure of oxygen in the surrounding environment [9]. The industrial production and 
utilization of cerium oxide (CeO2) nanoparticles is increasing rapidly in the polishing, energy, 
electronic, automobile and biomedical industries [8]. Recently, CeO2 nanoparticles have been 
used as catalysts in combustion engines to reduce particulate emissions and increase fuel 
efficiency [118]. Other work has demonstrated that CeO2 nanoparticles may exhibit antioxidant 
activity [111] which has led to the suggestion that these particles may be useful for the 
treatment of cardiovascular disease [10], neuronal injury [11] and for the prevention of 
radiation-induced damage [12].  
In addition to investigating the beneficial applications of CeO2 nanoparticles, other 
research has begun to examine whether these materials may also be toxic.  In vitro studies 
using A549 lung cancer cells [18] and bronchial alveolar epithelial cells (BEAS2B) [19] has 
suggested that cellular exposure to CeO2 nanoparticles may be associated with increased 
production of reactive oxygen species (ROS) and the induction of cellular apoptosis. Other work 
using the intact rat has demonstrated that CeO2 nanoparticles exposure can cause lung 
inflammation and fibrosis [17]. How exposure to CeO2 nanoparticles may induce lung 
inflammation and remodeling has not been fully elucidated.  
The mitogen activated protein kinases (MAPKs) including the extracellular signal-
regulated kinase (ERK1/2-MAPK), p38-MAPK and c-Jun amino terminal kinase (JNK) are a family 
of serine / threonine specific kinases that transduce extracellular stimuli and are involved in the 
regulation of cell proliferation, gene expression and apoptosis [79, 80]. Previous work has 
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suggested that several metals, including arsenic, zinc and chromium can induce the 
phosphorylation of MAPK proteins [119]. Whether exposure to CeO2 nanoparticles can elicit 
similar activity in the intact lung, has to our knowledge, not been examined.  
The primary goal of this study was to determine if exposure to CeO2 nanoparticles is 
associated with the activation of MAPK signaling and cellular apoptosis in the rat lung. Our data 
suggest that exposure to CeO2 nanoparticles is associated with an increased lung weight to 
body weight ratio, the accumulation of cerium in the lungs, elevations in serum inflammatory 
markers, an increased Bax to Bcl-2 ratio, elevated caspase-3 protein levels, increased 
phosphorylation of p38-MAPK and diminished phosphorylation of ERK1/2-MAPK (P<0.05).  
Taken together, these data suggest that exposure to CeO2 nanoparticles is associated with 
activation increased pulmonary ROS and cellular apoptosis.  
 
Materials and Methods 
Particle characterization  
CeO2 nanoparticles, average diameter at ~20 nm, were obtained from Sigma-Aldrich (St 
Louis, MO, USA) as previously outlined [17]. Normal saline was used to suspend the 
nanoparticles prior to instillation. Diluted particle suspensions were filtered, sputter coated, 
and examined with a Hitachi Model S-4800 Field Emission scanning electron microscope 
(Schaumburg, IL, USA) at 5 and 20 kV or placed on a formvar-coated copper grid to dry and 
imaged with a JEOL 1220 transmission electron microscope (Tokyo, Japan).  
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Animal handling and instillation of CeO2 nanoparticles 
All procedures were performed in accordance with the Marshall University Animal Care 
and Use Committee guidelines, using the criteria outlined by the Assessment and Accreditation 
of Laboratory Animal Care (AAALAC). Five week old (150-174 g) specific pathogen-free male 
Sprague-Dawley (Hla: SD-CVF) rats were purchased from Hilltop Lab Animals, Inc. (Scottdale, 
PA, USA). Rats were housed two per cage in an AAALAC approved vivarium with a 12-h light–
dark cycle and maintained at 22 ± 2° C. Animals were allowed access to food and water ad 
libitum. All animals were allowed to acclimatize for two weeks before initiation of the study. All 
animals were examined for precipitous weight loss, failure to thrive or unexpected gait. 
Periodic weight measurements were taken throughout the duration of the study. After 
acclimatization, animals were randomly divided into 12 groups (n=6 per group). Animals 
underwent instillation with 0.3 ml of saline suspension or CeO2 nanoparticles at a dosage of 7.0 
mg/kg as described elsewhere[17].  
 
Tissue collection 
Rats were anesthetized at 1, 3, 14, 28, 56 or 90 days post exposure with ketamine (40 
mg/kg) – xylazine (10 mg/kg) cocktail and supplemented as necessary for loss of reflexive 
response. After midline laparotomy, the lungs were removed and washed with oxygenated 
Krebs–Ringer bicarbonate buffer to remove any blood. After washing, lungs were trimmed of 
connective tissue, weighed and immediately snap frozen in liquid nitrogen. 
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Determination of cerium content in the lung 
Cerium content in the lung was estimated by induction coupled plasma-mass 
spectrometry (ICP-MS) at Elemental Analysis Inc. (Lexington, KY, USA) according to standard 
protocols. Cerium concentration was estimated for 1, 3, 14, 28 and 90 day post exposure 
groups. Briefly, lung samples (n=4 for each group) were prepared using EPA Method 3050B for 
the analysis of total cerium by ICP-MS.  A 1.0 g sample was weighed to the nearest 0.0001 g and 
digested with concentrated nitric acid, 30% hydrogen peroxide, and concentrated hydrochloric 
acid. A method blank, laboratory control sample, a laboratory duplicate, and a pre-digestion 
matrix spike were prepared for each sample.  After digestion, the extracts and the quality 
control samples were diluted to a final volume of 50 mL before analysis using an Agilent 7500cx 
ICP-MS. The instrument was calibrated for Ce-140 with 0, 0.1, 1.0, 10.0, and 100 μg/L standards 
prepared from a certified reference standard traceable to NIST reference materials. A second 
source calibration verification standard traceable to NIST reference materials was analyzed to 
verify the calibration standards. A continuing calibration verification standard and a continuing 
calibration blank were analyzed at the beginning of the run, after every ten samples, and at the 
conclusion of the run.  
 
Histopathological examination 
Tissues from lungs were embedded in paraffin wax, sectioned at 5-μm, mounted on 
glass slides and stained with hematoxylin-eosin using standard histopathological techniques. 
Sections were examined by light microscopy in a blinded fashion by a board certified 
pathologist. 
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Immunoblotting analysis  
Portions of individual lung tissues (100 - 150mg) were homogenized in buffer (T-PER, 8 
mL/g tissue; Pierce, Rockford, IL, USA) containing protease (P8340, Sigma-Aldrich, Inc., St. Louis, 
MO, USA) and phosphatase inhibitors (P5726, Sigma-Aldrich, Inc., St. Louis, MO, USA). Tissue 
homogenates were sonicated for three cycles for 30 sec at 150W. The supernatant protein was 
collected by centrifuging the tissue homogenate at 12,000 x g for 5 min at 4 °C. Protein 
concentration of homogenates was determined via the 660 nm assay method (Fisher Scientific, 
Rockford, IL, USA). Equal concentrations of the protein samples were prepared from individual 
animals by adding the equal quantities of Laemmli 2X sample buffer (Sigma- Aldrich, Inc., St. 
Louis, MO, USA) and adjusting the protein concentration with the T-PER lysis buffer. Samples 
were boiled in a Laemmli 2X sample buffer for 5 min. Thirty two µg of total protein for each 
sample was separated on a 10% PAGEr Gold Precast gel (Lonza, Rockland, ME, USA) and then 
transferred to nitrocellulose membranes. Gels were stained with a RAPID Stain protein stain 
reagent (G-Biosciences, St. Louis, MO, USA) to verify transfer efficiency to membrane. 
Membranes were stained with Ponceau S and the amount of protein quantified by 
densitometric analysis to confirm successful transfer of proteins and equal loading of lanes as 
detailed somewhere else[120]. Membranes were blocked with 5% milk in Tris Buffered Saline 
(TBS) containing 0.05% Tween-20 (TBST) for 1 h and then incubated with primary antibody 
overnight at 4°C. After washing with TBST, the membranes were incubated with the 
corresponding secondary antibodies conjugating with horseradish peroxidase (HRP) (anti-rabbit 
(#7074) or anti-mouse (#7076), Cell Signaling Technology, Danvers, MA, USA) for 1 h at room 
temperature. Protein bands were visualized following reaction with ECL reagent (Amersham 
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ECL Western Blotting reagent RPN 2106, GE Healthcare Bio-Sciences Corp., Piscataway, NJ, 
USA). Target protein levels were quantified by AlphaView image analysis software (Alpha 
Innotech, San Leandro, CA, USA). Primary antibodies against caspase-3 (#9662), cleaved 
caspase-3 (#9661S), Bax (#2772), Bcl2 (#2870S), caspase-9 (#9506), ERK1/2-MAPK Thr 
202/Tyr204 (#9106S), Phospho ERK1/2-MAPK Thr 202/Tyr204 (#4377S), JNK (#9252), Phospho 
JNK Thr 183/Tyr185 (#9251S), p38 MAPK (#9212), Phospho p38 MAPK Thr 180/ Tyr 182 
(#9216L), JAK2 (#3229), Phospho JAK2 Tyr1007/100 (#3776), STAT3 (#9132) and Phospho STAT3 
Tyr 705 (#9131S) were purchased from Cell Signaling  Technology (Beverly, MA, USA). 
 
Multiplexed serum protein immunoassays 
Pooled serum samples from six animals in 1, 3, 28 and 90 day exposure groups were 
shipped on dry ice to Rules Based Medicine (Austin, Texas) for Rodent MAP® version 2.0 
Antigen analysis using a Luminex 100 instrument as detailed elsewhere [121]. The antigen panel 
consisted of fifty-nine proteins, which included proteins involved in inflammation, cytokines, 
growth factors and tissue factors. Each analyte was quantified using 4 and 5 parameter, 
weighted and non-weighted curve fitting algorithms using proprietary data analysis software 
developed at Rules-Based Medicine. 
 
Data Analysis 
Results are presented as mean ± SEM. Data were analyzed using the Sigma Plot 11.0 
statistical program. One-way analysis of variance and two-way analysis of variance were 
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performed for overall comparisons, while the Student–Newman–Keuls post hoc test used to 
determine differences between groups. Values of P<0.05 were considered to be statistically 
significant. 
 
Results 
Nanoparticle characterization 
Similar to previous work[17], using the same batch of CeO2 nanoparticles, analysis of 
nanoparticle size by TEM and scanning electron microscopy (SEM) confirmed the presence of 
single and agglomerated CeO2 nanoparticles in the suspension as shown in early studies[17, 
121]. Field emission scanning electron microscopy showed that the CeO2 nanoparticles were 
generally dispersed into submicron groups with an average size of 9.26 ± 0.58 nm. The diameter 
of the primary CeO2 particles was determined to be 10.14 ± 0.76 nm by TEM (Figure 3.1). 
 
Exposure to CeO2 nanoparticles increases lung weight to body weight ratio 
Cerium oxide nanoparticles exposure had no effect on feed intake or body weight gain 
(data not shown). Compared to age-matched control animals, the lung weight to body weight 
ratio was higher for the CeO2 nanoparticles exposure group at each time point of exposure (Day 
1 control: 5.42± 0.66 vs. Day 1 CeO2 nanoparticles exposure: 5.84±0.24 (P<0.05), Day 3 control: 
4.97± 0.68 vs. Day 3 CeO2: 6.64±0.66 (P<0.05), Day 14 control: 5.55± 0.66 vs. Day 14 CeO2 
exposure: 6.40±0.89 (P<0.05), Day 28 control: 4.44± 0.38 vs. Day 28 CeO2 exposure: 6.03±0.69 
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(P<0.05), Day 56 control: 3.50± 0.57 vs. Day 56 CeO2 exposure: 6.30±1.19 (P<0.05), and Day 90 
control: 3.11± 0.27 vs. Day 90 CeO2 exposure: 5.27±0.64 (P<0.05) (Table 2). 
 
Accumulation of cerium in the lung with the days of post exposure 
The concentration of cerium in the lung was estimated with the elemental analysis 
technique ICP-MS (Elemental Analysis, Inc., Lexington, KY, USA). The concentration of cerium in 
the lung was decreased with increasing at 1- day post exposure (Post exposure Day 1: 250 ± 33 
ppm vs. Day 3: 223 ± 41 ppm vs. Day 14: 143 ± 12 ppm vs. Day28: 177 ± 38 ppm, and Day 90 
132 ± 31 ppm (P<0.05) (Figure 3.2). However, total cerium content in the lung tissue appears to 
increase post day 1 exposure that stays unaltered with the progression in the days of exposure 
(Data not shown). 
 
Exposure to CeO2 nanoparticles alters the gross histological appearance of the lung 
Alterations in appearance of the lungs following exposure to CeO2 nanoparticles 
included increased lung weight, the presence of black spots and white pustular nodules on the 
surface of the lungs that appeared to increase over time (Figure 3.3). Histological alterations 
included an increased number of alveolar macrophages, increased number of 
polymorphonuclear cells and the apparent accumulation of particulate material in the alveolar 
spaces (Figure 3.4). 
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CeO2 nanoparticles increase apoptotic protein signaling in the lung  
Compared to day 1 control animals, the Bax to Bcl-2 protein ratio in exposed animals 
was 16% higher at day 1 and 99% higher at day 3 post exposure (P<0.05) before  declining 
thereafter (Figure 3.5). Similarly, the Bax to Bcl-2 ratio was 37%, 23%, and 14% lower at days 
14, 28 and 56, respectively in CeO2 nanoparticles exposed animals. Conversely, the Bax to Bcl-2 
ratio was 22% higher for day 90 exposure animals compared to that observed in the day 1 
control animals. 
In an effort to extend these findings, we next examined the regulation of the initiator 
(caspase-9) and the executor caspases (caspase-3) [98]. Compared to day 1 control animals, 
total caspase-9 protein levels were reduced by 28%, 6%, 23%, 5%, 21%,  and 32% (P<0.05) in 
the day 1, 3, 14, 28, 56, and 90 exposure groups, respectively (P<0.05). Compared to saline day 
1 controls, the expression of the 38kDa and 40 kDa cleaved fragments of caspase-9 was 
increased 20%, 20%, and 20% for day3, day 14 and day 28 post exposure groups, respectively 
(P<0.05; Figure 3.6). 
Caspase-3 protein expression levels were increased by 56% (P<0.05) and 20% (P<0.05) 
for the day 3 and 14 exposure groups when compared to day 1 controls. Compared to saline 
day 1 control animals, the amount of cleaved caspase-3 (17kDa and 19 kDa) was increased by 
10%, 88%, 66%, 119%, 77%, and 39% higher for the day 1, 3, 14, 28, 56 and 90 exposure groups 
(P<0.05; Figure 3.7).  
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CeO2 nanoparticle exposure is associated with activation of MAPK signaling 
Compared to day 1 controls, the ratio of phosphorylated p38 MAPK (Thr180/Tyr182) to 
total p38 MAPK was 22% and 14% lower for day1 and day3 post exposure groups (P<0.05). 
Conversely, this ratio was elevated by 52%, 15%, and 10% for day 14, 28 and 56 exposure 
groups, before declining by 19% in the 90 day animals (P<0.05; Figure 3.8).  
The ratio of phosphorylated ERK1/2-MAPK (Thr202/Tyr204) to total ERK1/2-MAPK was 
reduced by 43%, 57%, 56%, 62%, 53% and 41% at day 1, 3, 14, 28, 56 and 90 post exposure 
groups when compared to day 1 saline controls (P<0.05; Figure 3.9). There were no significant 
differences in the expression of phosphorylated (Thr183/Tyr185) JNK to total JNK ratio with the 
nanoparticle exposure (Figure 3.10).   
 
CeO2 nanoparticles increase inflammatory protein signaling  
It is known that JAK2 and STAT3 play crucial roles in the inflammation[104]. When 
compared to saline control day1, phosphorylated (Tyr705) to total STAT3 protein levels were 
111%, 193%, 106%, 15% and 20% higher for day 3, 14, 28, 56 and 90 exposure groups (P<0.05; 
Figure 3.11). Phosphorylated (Tyr1007/1008) JAK2 to total JAK2 ratio was 25%, 23%, and 103% 
(P<0.05) higher for the day 1, 56, and 90 animals when compared to saline control animals 
(Figure 3.12). 
In order to determine the role of inflammatory mediators that are released into the 
circulation, we determined the expression of serum biomarkers that include inflammatory 
cytokines, interleukins, chemokines, tissue factors and growth factors. Among the 55 
parameters, we have included 12 parameters that are thought to play an important role in the 
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inflammation. Data are presented as percentage change in the expression when compared with 
the saline control day 1. Compared to saline control day 1, CeO2 nanoparticle exposure at day 1 
has increased the expression of all the parameters that are under the study (Figure 3.13 a). 
Compared to saline control day 1, post exposure day 3 group showed elevation of expression 
for 3 parameters, lowered expression for 8 parameters and no changes in the expression of 1 
parameter (Figure 3.13 b). Compared to saline control day1, day28 post exposure group 
showed an elevation of 4 parameters, a lowered expression for 7 parameters and no change in 
the expression of 2 parameters (Figure 3.13 c). Compared to saline control day 1, day 90 post 
exposure group showed lowered expression for 10 parameters and no change in the expression 
for 2 parameters (Figure 3.13 d). 
 
Discussion 
Previous in vitro and in vivo studies have suggested that exposure to CeO2 nanoparticles 
can elicit toxic effects; however the underlying mechanism(s) is not well understood [16-18, 
118]. The primary findings of the current work are that pulmonary exposure to CeO2 
nanoparticles is associated with increases in the lung to body weight ratio, histological evidence 
of lung inflammation, the activation of MAPK signaling, the phosphorylation of STAT-3, 
increases in caspase-3 cleavage, and inflammation.  
Our data demonstrated that exposure to CeO2 nanoparticles results in increased lung 
weight to body weight ratio (Table 2). To determine the potential mechanism of increased lung 
weight we next examined the lungs for the presence of CeO2 nanoparticles. As indicated by our 
ICP-MS data, the instillation of CeO2 nanoparticles leads to the deposition of cerium in the lungs 
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(Figure 3.2). Whether this cerium deposition is responsible for the increased lung to body 
weight ratio is currently unclear. With increased lung to body weight ratio we also observed 
that exposure to CeO2 nanoparticles was associated with the development of white nodular 
structures on the lung surface (Table 2, Figures 3.3 and 3.4). Recent work has shown that 
nanoparticles such as carbon nanotubes, TiO2 nanoparticles, and polyacrylate nanoparticles can 
induce granulomas on the lung surface [49, 122, 123]. It is possible that the white nodules we 
observed in the present study may be the byproduct of an ongoing inflammatory reaction, 
which could result in either the clearance of the nanoparticles or advance further to form 
granulomas on the surface of lungs [123, 124]. The aforementioned possibility is consistent 
with our histopathological analysis where we observed an increase in the number of alveolar 
macrophages and polymorph nuclear white blood cells in the lungs of animals that had been 
exposed to the CeO2 nanoparticles. It is thought that the toxic effects of most nanoparticles 
(silver, silica, titanium dioxide, zinc oxide and carbonaceous nanoparticles) are characterized by 
increased oxidative stress [24, 73, 125-127]. Whether these increases in oxidative stress are due 
to increased ROS generation or decreased ROS scavenging is currently unclear, however, many 
metallic oxide nanoparticles have been shown to increase ROS production [1, 102].  
Increase in the ROS may also induce apoptotic signaling. Here, we observed an increase 
in the proapoptotic Bax to Bcl-2 ratio after 3 days of the exposure before declining thereafter 
(Figure 3-5). Given that the Bax to Bcl-2 ratio is a primary determinant of whether a cell 
undergoes apoptosis or survival [97, 98] we next examined the possibility that CeO2 
nanoparticle exposure is associated with the activation of caspase-3. Consistent with the 
Bax/Bcl-2 data, we found that caspase-3 cleavage (activation) is elevated at days 3, 14, 28 and 
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56. Why caspase-3 cleavage may exist in the absence of elevation in the Bax/Bcl-2 ratio is 
currently unclear. Other signaling pathways (extrinsic or intrinsic pathway) that activate the 
apoptotic pathway may explain the possible activation of effector caspase 3 in the absence of 
elevated Bax/Bcl-2 ratio. It is thought that mild lung injury will result in repair of the damaged 
tissue whereas excessive apoptotic cell death may lead to the development of lung remodeling 
and fibrosis [128]. Bearing this in mind, the activation of caspase 3 we find in the current study 
may help to explain the findings of increased lung fibrosis following CeO2 nanoparticle exposure 
shown in previous work [17].  
The MAPKs are stress responsive proteins that can be activated by the growth factors, 
chemicals, ultraviolet radiation, heat, synthesis inhibitors, metals or foreign organisms [129]. 
The MAPKs pathway plays an important role in the nanoparticle and metal induced oxidative 
stress and inflammation [102, 119]. The primary members of the MAPKs signaling family 
include p38 MAPK, JNK-MAPK and ERK1/2-MAPK. MAPKs proteins are thought to 
phosphorylate (activate) transcription factors that are involved in regulating the cell survival or 
death. Here we observed that CeO2 nanoparticle exposure is associated with increased p38 
MAPK phosphorylation at days 14, 28 and 56 of exposure. Conversely, we found that ERK1/2-
MAPK activity appeared to be impaired by CeO2 nanoparticles (Figures 3.8 and 3.9). Given that 
ERK1/2- MAPK is thought to play an important role in cell survival and that p38 MAPK may play 
an important role in apoptosis [129], these differences in MAPK signaling may help to explain 
the discrepancies that we observed in the proapoptotic Bax to Bcl-2 ratio.  
It is well known that nanoparticle exposure is often associated with increased levels of 
inflammatory mediators such as cytokines, interleukins and other mediators of inflammation [1, 
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73, 102]. The Janus kinase / signal transducers and activators of transcription (JAK/STAT) 
pathway is a particularly important pathway in mediating inflammation [104]. Interestingly, 
JAK2 did not appear to have an important role in the toxicological response, as its 
phosphorylation (Tyr1007/1008) was elevated only at day 1 and day 90 of exposure (Figure 
3.12). Conversely the phosphorylation of STAT-3 (Tyr705) seemed to parallel p38 MAPK 
activation (Figure 3.11). Previous work has demonstrated that p38 MAPK can act as an 
upstream activator of STAT-3, which when activated, can induce apoptosis [106]. These data, 
considered together with our findings of an increased Bax/Bcl-2 ratio, are consistent with the 
possibility that CeO2 nanoparticles induced apoptosis is mediated through the activation of the 
p38 MAPK and STAT-3 signaling pathways.   
In addition to evidence for increased inflammatory signaling, we also noted increased 
levels of several inflammatory cytokines and chemokines (Figures 3.13a, b, c and d). Of 
particular note was the finding that CD40 Ligand (CD40L) was elevated at day1 and 3 post 
exposure. Previous studies using ultrafine particles present in the air pollutants and diesel 
exhausts showed activation of CD40L which can strongly activate CD40 bearing cells such as 
white blood cells, endothelial cells and platelets  and thereby can cause increased coagulation 
and inflammation [130]. It is also thought that CD40L plays an important role in activating 
macrophages where it causes macrophages to increase their phagocytic activity. Other work 
has shown that CD40L can induce the production of IL-4 by T-cells [130] (Figure-13a). Whether 
this activity is the cause of the increased levels of IL-4 seen in the current study, is currently 
unclear. Other studies have shown that CD40L can induce endothelial cells to produce ROS, 
chemokines and cytokines that can damage the cell [131]. In addition to CD40L, we also noted 
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the increased expression of several other serum chemokines and cytokines including IL-7, IL-1 
alpha, monocyte chemo attractant proteins (MCP) and Eotaxin; all of which are thought to play 
an important role in inflammation [73, 132, 133]. How these factors may work together to 
cause the inflammatory response we observe in the present study is unfortunately, beyond the 
scope of the current study and will require additional experimentation.  
In summary, our data suggest that exposure to CeO2 nanoparticles can increase lung to 
body weight ratio and the increased lung weights are associated with increased accumulation 
of cerium in the lungs. Our studies demonstrated that exposure to CeO2 nanoparticles can 
cause gross and histological alterations to lungs. CeO2 nanoparticles appear to activate 
oxidative stress, inflammation and apoptotic protein signaling in the lungs. Data from our 
studies demonstrate that the apoptosis induced by CeO2 nanoparticles appears to be mediated 
through activation of caspase protein signaling. Given these findings, additional research to 
evaluate the role of subcellular organelles in inducing the apoptosis is likely warranted. 
 
48 
 
Table 2: CeO2 nanoparticle exposure increases the lung weight to body weight ratio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† Significantly different from the control in each day of exposure 
*Significantly different from the 1 Day exposure group in each condition 
α
 Significantly different from the 3 Day exposure group in each condition 
μ Significantly different from the 14 Day exposure group in each condition 
¶ Significantly different from the 28days exposure group 
# Significantly different from the 56days exposure group 
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Figure 3-1: Characterization of the cerium oxide nanoparticles by (a) TEM micrograph (scale bar 
= 200 nm) and (b) Field emission SEM of a dilute cerium oxide suspension. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a b 
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Figure 3-2:  Cerium deposition in the lung appears to diminish over time.  
Con-1 represents saline control day1, CeO2-1, 3, 14, 28 and 90 represents animal groups post 
exposed to CeO2 nanoparticles at 1, 3, 14, 28 and 90 days respectively.    
 
 
 Significantly different from the saline control day-1 
† Significantly different from the CeO2-day-1 
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Figure 3-3: Gross alterations in the lungs with CeO2 nanoparticles instillation include increases 
in the lung weight, appearance of white nodules on the surface (Arrow) and appearance of 
black spots on lung surface 
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Figure 3-4: Alterations in histological appearance of lungs with CeO2 nanoparticle instillation 
include increases in the number of alveolar macrophages, increases in the polymorphonuclear 
white blood cells (Arrow head) and increased accumulation of particulate matter (Arrow) in the 
air spaces (400X) 
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Figure 3-5: CeO2 nanoparticles can increase the proapoptotic protein signaling in the lungs. 
Protein bands of the Bax and Bcl-2 proteins and corresponding GAPDH are represented in the 
figure. Bands corresponding to the X-axis labels are shown in the immunoblotting images. 
Protein levels were adjusted by GAPDH levels and compared with the control day-1. 
 
 Significantly different from the saline control day-1 
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Figure 3-6:  Increased expression of initiator caspase-9 with CeO2 nanoparticles instillation. 
Protein bands of the caspase-9 and cleaved caspase-9 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 Significantly different from the saline control day-1 
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Figure 3-7: Increased expression of executor caspase-3 with CeO2 nanoparticles exposure. 
Protein bands of the caspase-3 and cleaved caspase-3 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 Significantly different from the saline control day-1 
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Figure 3-8: Activation of p38 MAPK activity with the CeO2 nanoparticles instillation. 
Protein bands of the p38MAPk and Phospho p38 MAPK proteins and corresponding GAPDH are 
represented in the figure Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 Significantly different from the saline control day-1 
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Figure 3-9: Inhibition of ERK1/2-MAPK activity with the CeO2 nanoparticles instillation. 
Protein bands of the ERK1/2-MAPK and Phospho ERK1/2-MAPK proteins and corresponding 
GAPDH are represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 
 Significantly different from the saline control day-1 
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Figure 3-10: CeO2 nanoparticles do not appear to modulate the JNK activity. 
Protein bands of the JNK and Phospho JNK proteins and corresponding GAPDH are represented 
in the figure. Bands corresponding to the X-axis labels are shown in the immunoblotting images. 
Protein levels were adjusted by GAPDH levels and compared with the control day-1. 
 
 
 Significantly different from the saline control day-1 
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Figure 3-11: Activation of STAT-3 with CeO2 nanoparticles exposure follows the activation of 
p38 MAPK. 
Protein bands of the STAT-3 and Phospho STAT-3 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 
 Significantly different from the saline control day-1 
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Figure 3-12: Alteration in the expression of JAK2 protein expression with CeO2 nanoparticles 
instillation. 
Protein bands of the JAK2 and Phospho JAK2 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 Significantly different from the saline control day-1 
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Figure 3-13: Activation of pro-inflammatory cytokines and chemokines in the serum with CeO2 
nanoparticles exposure 
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Paper-II 
Specific Aim-2: To investigate if intratracheal instillation of CeO2 nanoparticles has any toxic 
effects on the liver, kidney, spleen and heart of rats 
 
Note: Animal studies and procedures such as exposure to CeO2 nanoparticles and scarifying of 
the animals mentioned in this part were conducted at NIOSH, where we collected the vital 
organs such as liver, kidney, spleen and heart and used to perform the experiments explained 
in this part. 
 
Note: This paper has been previously published: 
Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-
Dawley rats. Nalabotu SK, Kolli MB, Triest WE, Ma JY, Manne ND, Katta A, Addagarla HS, Rice 
KM, Blough ER. Int J Nanomedicine. 2011; 6: 2327-35. Epub 2011 Oct 14 
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Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male 
Sprague Dawley rats 
 
Abstract 
Cerium oxide (CeO2) nanoparticles have been posited to have both beneficial and toxic 
effects on biological systems. Herein, we examine if a single intratracheal instillation of CeO2 
nanoparticles (1.0 mg/kg, 3.5 mg/kg or 7.0 mg/kg) after 28 days is associated with systemic 
toxicity in male Sprague-Dawley rats. Compared to control animals, CeO2 nanoparticle exposure 
was associated with increased liver ceria levels, elevations in serum alanine transaminase 
levels, reduced albumin levels, diminished sodium-potassium ratio and decreased serum 
triglyceride levels (P<0.05). Consistent with these data, rats exposed to CeO2 nanoparticles also 
exhibited reductions in liver weight (P<0.05) and dose dependent hydropic degeneration, 
hepatocyte enlargement, sinusoidal dilatation and the accumulation of granular material. No 
histopathological alterations were observed in the kidney, spleen and heart. Analysis of the 
serum biomarkers suggested that there was an elevation of acute phase reactants and markers 
of hepatocytes injury in the CeO2 nanoparticles exposed rats. Taken together, these data 
suggest that intratracheal instillation of CeO2 nanoparticles can result in liver damage.   
 
Key words: cerium oxide nanoparticles, systemic toxicity, hepatic toxicity and hydropic 
degeneration   
Running Title: Cerium oxide nanoparticles can cause hepatic toxicity 
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Introduction 
Cerium is a rare earth lanthanide metal that is a strong oxidizing agent. Cerium exists 
both in the trivalent (Ce3+, cerous) and in a very stable tetravalent state (Ce4+, ceric) as cerium 
oxide (CeO2) [8]. CeO2 is widely used as a polishing agent for glass mirrors, television tubes and 
ophthalmic lenses [7]. In addition, CeO2 can also act as a catalyst as it can both accept and give 
up oxygen [134]. This latter property has led to the widespread use of CeO2 in the automobile 
industry where it has been used to increase fuel efficiency and reduce particulate emissions 
[108, 109, 118]. It appears that CeO2 nanoparticles may also be capable of acting as 
antioxidants which has led some to postulate that these particles may be useful for the 
treatment of cardiovascular disease [10], neurodegenerative disease [11] and radiation-induced 
tissue damage [12, 135]. Nonetheless, other in vitro work has shown that CeO2 nanoparticles 
can also cause oxidative stress [19].  
The Organization for Economic Co-operation and Development (OECD) Working Party 
on Manufactured Nanomaterials (WPMN) has demarcated CeO2 nanoparticles along with 
fourteen other nanoparticles as a high-priority for evaluation [136]. Given current industrial 
applications, it is thought that the most common route of CeO2 exposure is likely to be through 
inhalation and/or ingestion. Although previous studies have shown that intratracheal 
instillation of CeO2 nanoparticles can cause a toxicological response in the lung, whether these 
particles also exhibit systemic toxicity is currently unclear [7, 17]. The purpose, therefore, of the 
current study was to determine if the intratracheal instillation of CeO2 nanoparticles is 
associated with indices of systemic toxicity and pathological change. On the basis of previous 
work examining the translocation of carbon nanotubes from the lung [137], we hypothesized 
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that intratracheal instillation of CeO2 nanoparticles may be associated with nanoparticle 
deposition in other organs through the circulation. Consistent with this hypothesis, our data 
suggest that the intratracheal instillation of CeO2 nanoparticles is associated with increased 
liver ceria levels, reductions in liver weight and evidence of liver damage.  
 
Materials and Methods 
Particle characterization  
CeO2 nanoparticles, 10 wt % in water (average diameter at ~20 nm), were obtained from 
Sigma-Aldrich (St Louis, MO, USA) as previously outlined 13. Normal saline was used as vehicle 
to suspend the nanoparticles prior to instillation. Diluted particle suspensions were also 
filtered, sputter coated, and examined with a Hitachi Model S-4800 Field Emission scanning 
electron microscope (Schaumburg, IL, USA) at 5 and 20 kV or placed on a formvar-coated 
copper grid to dry and imaged with a JEOL 1220 transmission electron microscope (Tokyo, 
Japan).  
 
Animal handling and instillation of CeO2 nanoparticles 
Specific pathogen-free male Sprague-Dawley (Hla: SD-CVF) rats (6 weeks old) were 
purchased from Hilltop Laboratories (Scottdale, PA, USA). Rats were kept in cages individually 
and ventilated with HEPA filtered air in an animal facility accredited by the Association for 
Assessment and Accreditation of Laboratory Animal Care International. After acclimatization for 
1 week, rats were randomly divided into four groups (n=7 per group): vehicle control (saline, 
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0.9% NaCl), or instillation with 1.0, 3.5, or 7.0 mg/kg CeO2 nanoparticles. Rats were 
anesthetized and placed on an inclined restraint board before instillation with 0.3 ml of saline 
suspension or CeO2 nanoparticles. Animals were euthanized 28 days post-exposure by drug 
overdose using the combination of xylazine and ketamine according to the Guide for the Care 
and Use of Laboratory Animals and as approved by the National Institute for Occupational 
Safety and Health Animal Care and Use Committee. All animals were humanely treated and 
were monitored for any potential suffering.  
 
Determination of cerium content in the liver 
Liver cerium content was estimated by Induction Coupled Plasma-Mass Spectrometry 
(ICP-MS) at Elemental Analysis Inc. (Lexington, KY, USA) according to standard protocol [137]. 
Briefly, liver samples (n=4 for each group) were prepared using EPA Method 3050B for the 
analysis of total Cerium by ICP-MS.  A 2.5 g sample was weighed to the nearest 0.0001g and 
digested with concentrated nitric acid, 30% hydrogen peroxide, and concentrated hydrochloric 
acid.  A method blank, laboratory control sample, a laboratory duplicate, and a pre-digestion 
matrix spike were prepared for each sample.  After digestion, the extracts and the quality 
control samples were diluted to a final volume of 50 mL before analysis using an Agilent 7500cx 
ICP-MS. The instrument was calibrated for Ce-140 with 0, 0.1, 1.0, 10.0, and 100 μg/L standards 
prepared from a certified reference standard traceable to NIST reference materials. A second 
source calibration verification standard traceable to NIST reference materials was analyzed to 
verify the calibration standards. A continuing calibration verification standard and a continuing 
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calibration blank were analyzed at the beginning of the run, after every ten samples, and at the 
conclusion of the run.  
 
Serum biochemical and lipid profile analysis 
Blood was collected from the euthanized animals by cardiac puncture into a serum 
collection tube (BD Vacutainer® SST™ Tubes; #367986) before centrifugation at 800 x g for 15 
minutes. Serum was collected and used for biochemical assays using Abaxis VetScan® analyzer 
(Abaxis, Union City, CA, USA). Serum biochemical parameters: alanine aminotransferase (ALT), 
alkaline phosphatase (ALP), bilirubin, blood urea nitrogen (BUN), albumin (ALB), calcium (Ca+2), 
creatinine (CRE), amylase (AMY), globulin (GLOB), potassium (K+), sodium (Na+), phosphorous 
(PHOS), total bilirubin (TBIL) and total protein were evaluated with a Comprehensive Diagnostic 
Profile Disk. The lipid profile: total cholesterol, triglycerides and HDL were measured using lipid 
profile-Glu cassettes (Cholestech LDX) and a Cholestech LDX® analyzer. The remaining serum 
was stored at -80 °C. 
 
Multiplexed serum protein immunoassays 
Pooled serum samples from all 7 animals in each experimental group were shipped on 
dry ice to Rules Based Medicine (Austin, Texas) for RodentMAP® version 2.0 Antigen analysis 
using a Luminex 100 instrument as detailed elsewhere [137]. The antigen panel consisted of 
fifty-nine proteins, which included proteins involved in inflammation, cytokines, growth factors 
and tissue factors. Each analyte was quantified using 4 and 5 parameter, weighted and non-
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weighted curve fitting algorithms using proprietary data analysis software developed at Rules-
Based Medicine. 
 
Tissue collection 
Liver, kidney, spleen and heart were collected at the time of death. Each tissue was 
weighed and then fixed in FineFIX™ (Milestone Medicals, Shelton, Connecticut) preservative for 
later histopathological examination. 
 
Histopathological examination 
Tissues from liver, spleen, kidney and heart were embedded in paraffin wax, sectioned 
at 5-μm, mounted on glass slide and stained with hematoxylin-eosin using standard 
histopathological techniques. Sections were examined by light microscopy in a blinded fashion 
by a board certified pathologist.  
 
Data Analysis 
Results are presented as mean ± SEM. Data were analyzed using the SigmaPlot 11.0 
statistical program. One-way analysis of variance  was performed for overall comparisons, while 
the Student–Newman–Keuls post hoc test used to determine differences between groups [17]. 
Values of P<0.05 were considered to be statistically significant. 
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Results 
Nanoparticle characterization 
Similar to previous work using the same batch of CeO2 nanoparticles 
13, analysis of 
nanoparticle size by TEM and SEM confirmed the presence of single and agglomerated CeO2 
nanoparticles in the suspensions.  
 
CeO2 instillation decreases liver wet weight 
CeO2 instillation had no significant effect on rat body, heart, kidney, or spleen weight. 
Compared to control animals, CeO2 instillation decreased liver weight (Saline control 14.55 ± 
0.27 vs. CeO2 7.0 mg/kg 12.50 ± 0.54; P< 0.05, Table 3).   
 
CeO2 instillation increases liver ceria content  
The ceria content of animals instilled with 7.0 mg/kg CeO2 nanoparticles was higher than 
that observed in the other groups (Saline control: non-detectable vs. 1.0 mg/kg CeO2 0.05 ± 
0.01 ppm vs. 3.5 mg/kg CeO2 0.11 ± 0.02 ppm vs. CeO2 7.0 mg/kg: 0.50 ± 0.18 ppm; P< 0.05; 
Figure 3.14).  
 
Effect of CeO2 instillation on serum biochemical profile 
Table 4 shows the alterations of the serum biochemical parameters following CeO2 
nanoparticle exposure. Compared to control animals, CeO2 instillation increased serum ALT 
levels, reduced albumin levels and diminished the sodium-potassium ratio. The serum lipid 
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profile analysis (Table 4b) indicated a reduction in the triglyceride levels with CeO2 nanoparticle 
exposure.  
 
CeO2 nanoparticle exposure is associated with evidence of liver pathology 
The primary alterations considered for liver tissue damage were hydropic degeneration 
of the hepatocytes, dilation of the sinusoids, portal inflammation and fibrosis of the liver. 
Alterations considered for the kidney pathologies were necrosis of the proximal tubular 
epithelium, tubular accommodation of proteinaceous material, and inflammatory reaction in 
the interstitial areas of the cortex and medulla. For the spleen and heart tissues were examined 
for any histological alterations in structure along with the infiltration of inflammatory cells. 
CeO2 nanoparticle exposure showed wide spread hydropic degeneration of the 
hepatocytes around the central vein region with sparing of the immediate peri-portal region 
when compared with the controls (Figure 3.15). These changes were pan-lobular in nature. 
Along with hydropic degeneration, we also observed enlargement of the hepatocytes, 
enlargement of the nucleus in the hepatocyte, binucleation of some hepatocytes, dilatation of 
the sinusoids, and occasional focal necrosis areas in few of the exposed animals. As the dose of 
the nanoparticles was increased, the number of hepatocytes that show hydropic degeneration 
was also elevated suggesting that changes in hepatocyte structure were dose dependent. There 
was no evidence of granuloma, portal inflammation, fibrosis, or bile duct abnormalities except 
for the presence of some local inflammation of the lobules in some animals. We did not 
observe any alterations in the histological appearance or the infiltration of inflammatory cells in 
the heart, kidney and spleen with CeO2 nanoparticle exposure. 
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Effect of CeO2 instillation on serum protein expression 
A panel of 59 protein biomarkers comprising cytokines, inflammatory markers, growth 
factors, and tissue factors were quantified in the serum samples collected in this study using 
the RBM RodentMAP®V2.0 multiplex immune assay service. Only the biomarkers which showed 
alterations in the serum protein biomarkers with the different experimental doses are depicted 
in Figure 3.16; Panels a, b, c). Among the 59 analytes, 20 analytes showed consistent changes 
across all the experimental groups. Among these 20 analytes, 8 analytes were up-regulated for 
CeO2 1.0 mg/kg dose group, 9 analytes were down regulated and 3 analytes did not change. For 
the 3.5 mg/kg CeO2 dose group, 12 analytes were up regulated, 7 were down regulated and 1 
did not change. Similarly, for the 7.0 mg/ kg CeO2 exposure, 17 analytes were up regulated, 
while 3 analytes were down regulated. Analytes that were elevated in all the experimental 
groups include: C-reactive protein, eotaxin, fibroblast growth factor-basic, haptoglobin, 
immunoglobulin-A, matrix metalloproteinase-9, serum amyloid-protein, serum glutamic 
oxaloacetic transaminase (SGOT) and thrombopoietin (TPO), vascular endothelial growth 
factor-A (VEGF-A) and von Willebrands’s factor (vWF). 
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Discussion 
Investigation of the effects that nanomaterials may have on cellular function is essential 
for ensuring that the utilization of these materials in industrial or medical applications is safe. 
Although CeO2 nanoparticles have demonstrated excellent potential for biomedical use [10], 
[11],[12] limited knowledge exists concerning potential systemic toxicity. The primary finding of 
this investigation was that the intratracheal instillation of CeO2 nanoparticles results in 
increased liver ceria levels (Figure 3.14) and that these changes in liver ceria are associated with 
evidence of liver pathology (Figure 3.15), decreases in liver weight (Table 3) and alterations in 
blood chemistry (Table 4). Consistent with other reports examining CeO2 [113], titanium dioxide 
[138], silica [139] and copper [140] nanoparticles, our data suggest that it is possible that CeO2 
nanoparticles are capable of translocating from the lung to the liver via the circulation.  
The histopathological appearance of the liver following CeO2 nanoparticle instillation is 
consistent with the possibility that ceria can induce several different pathological alterations 
including hydropic degeneration of the hepatocytes, enlargement of the hepatocytes, dilatation 
of the sinusoids and nuclear enlargement (Figure 3.15). As liver is the major organ for 
biotransformation of the toxins, it may be the first organ to be exposed to nanoparticles that 
are able to enter into the circulation. It is thought that hydropic degeneration can be caused by 
hypoxia [141], ischemia [142]  or the treatment of hepatocytes with endotoxins [143] or 
chemicals [144]. Consistent with our findings, this response has also been observed following 
exposure to other toxic materials including copper nanoparticles [145] and carbon tetrachloride 
[146] or following the inhalation of anesthetics such as sevofulrane and desflurane [147].  How 
exposure to CeO2 nanoparticles may induce hydropic degeneration or if these changes are 
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reversible is currently unclear.  Sinusoidal dilatation is the increased gap between the hepatic 
cords in the hepatic lobule. Sinusoidal dilatation is a pathological change that has also been 
observed in aluminum-induced hepatic toxicity [148], carbon tetrachloride-induced hepatic 
toxicity [149], ischemia [150], as well as with the organophosphate insecticide mathidathion 
[151]. In addition, we also noted the accumulation of granular material inside the hepatocytes 
which appeared to be dose-dependent and perhaps related to the reduction of liver weight 
(Table 3). The molecular mechanism(s) responsible for this accumulation are unknown and will 
require further investigation.   
To complement our study of liver histopathology we also investigated the effects that 
ceria might have on blood chemistry. Our data suggest that CeO2 nanoparticle instillation in the 
rat is associated with an elevation of ALT and reductions in albumin (Table 4). It is well 
established that hepatocyte damage is associated with the release of liver enzymes into the 
circulation and reduced albumin levels [148]. In addition to changes in the level of circulating 
liver enzymes, CeO2 nanoparticle instillation also appears to decrease the sodium-potassium 
ratio and the amount of triglycerides (Table 4). Whether alterations in the sodium-potassium 
ratio or triglyceride levels can be directly attributed solely to changes in liver, kidney or adrenal 
function or some combination thereof is currently unclear however it is interesting to note that 
these changes appear to occur coincident with decreases in liver weight.  
To identify potential serum biomarkers following CeO2 nanoparticle exposure, we 
examined 59 different analytes. Of the analytes studied, 20 biomarkers showed changes across 
all the groups. This may indicate that inhaled exposure to CeO2 nanoparticles may trigger the 
concurrent activation of several biochemical pathways. Similar to other work examining other 
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types of nanoparticles [152, 153], we observed elevations in the amount of C-reactive protein 
(10%), haptoglobin (16%), serum amyloid-p protein (24%) and von Willebrand’s factor (33%) 
following exposure to the CeO2 nanoparticles. Consistent with our histopathological findings, 
and the possibility of hepatic injury, we also found evidence that CeO2 nanoparticle instillation 
was associated with increases in the amount of serum thrombopoietin, fibroblast growth 
factor, SGOT and TPO (Figure 3.16).  Elevation in these serum biomarkers is thought to be 
highly correlated with acute hepatic damage [144],[154]. Taken together, these data suggest 
that ceria deposition may be associated with liver damage. Given our findings that CeO2 
nanoparticle instillation, at least at the levels used in the current study, does not induce 
appreciable damage to the heart, kidney or spleen, it is possible that the liver, by acting to clear 
CeO2 nanoparticles from the circulation, is functioning to prevent additional secondary or 
tertiary toxicological pathophysiology.  
 
Conclusion 
In summary, our data suggest that intratracheal instillation of CeO2 nanoparticles can 
induce hepatotoxicity resulting in the potential loss of hepatic mass and function. The toxicity 
induced by the CeO2 nanoparticles appear to be dose-dependent and the rats exposed with the 
7.0 mg/kg body weight of the CeO2 nanoparticles showed maximal toxic response when 
compared with other dosage groups. The toxicological response appears to be limited to the 
liver and may occur through extra pulmonary translocation of the CeO2 nanoparticles into the 
systemic circulation. Given these findings, additional research to evaluate the health effects of 
CeO2 nanoparticles is likely warranted. 
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Table 3:  Alterations in the absolute organ wet weight 28 days after the intratracheal instillation 
of cerium oxide nanoparticles. * Indicates significantly different from the vehicle control (p 
<0.05) 
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Table 4:  Changes in the serum biochemical parameters (a) and lipid profile (b) 28 days after the 
intratracheal instillation of cerium oxide nanoparticles. * Indicates significantly different from 
the vehicle control (P<0.05).  
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Figure 3-14: Concentration of cerium in the liver following intratracheal instillation of cerium 
oxide nanoparticles * Indicates significantly different from the vehicle control (P<0.05). 
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Figure 3-15: Cerium oxide nanoparticle exposure alters histopathological architecture of the 
liver. Panel a: saline control (400X), b: CeO2 at 1.0 mg/kg (400X), c: CeO2 3.5 mg/kg (400X) and 
d: CeO2 7.0 mg/kg (400X). Note evidence of hydropic degeneration (arrow) with CeO2 
instillation. 
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Figure 3-16: Cerium oxide nanoparticles exposure results in alterations in the expression of 
serum protein biomarkers.  
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Role of Oxidative Stress and Apoptosis in the Hepatic Toxicity induced by Cerium Oxide 
Nanoparticles Following Intratracheal Instillation in Male Sprague-Dawley Rats 
 
Abstract 
Inhaled cerium oxide (CeO2) nanoparticles have been shown to be capable of 
translocation to the liver where they can cause dose dependent toxic effects [121]. Herein, we 
investigate if the deposition of ceria in the liver is associated with increased oxidative stress and 
cellular apoptosis. Specific pathogen free male Sprague-Dawley rats were instilled with either 
vehicle (saline) or CeO2 nanoparticles (7.0 mg/kg) and euthanized 1, 3, 14, 28, 56, or 90 days 
post exposure. Liver samples were evaluated for evidence of ceria deposition, oxidative stress 
and apoptosis. Inductively coupled plasma mass spectroscopy demonstrated that ceria 
deposition increased over time. Analysis of lipid peroxidation, superoxide levels and number of 
TUNEL positive cells revealed evidence of increased oxidative stress and apoptosis at 1, 3, and 
90 days post exposure. Immunoblotting showed that each of these time points was 
characterized by increases in the Bax/Bcl-2 ratio, elevations in caspase-9 protein levels and 
increased caspase-3 protein expression. Interestingly, we found no evidence of oxidative stress 
or apoptosis at day 14, 28, or 56 post-exposure. Taken together, these data demonstrate that 
the intratracheal instillation of CeO2 nanoparticles is associated with increased liver ceria 
deposition and that this deposition causes a biphasic oxidative stress and apoptotic response.   
 
Key words: Cerium oxide nanoparticles, bioaccumulation, hepatic toxicity, oxidative stress, lipid 
peroxidation and apoptosis 
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Introduction 
 CeO2 nanoparticles have been used as catalysts to increase fuel efficiency of automobile 
engines and to reduce particulate emissions from the incomplete combustion of fuels [25]. 
Recent data has also suggested that CeO2 nanoparticles may also have biomedical use as 
potential scavengers of reactive oxygen species (ROS) to protect against cardiomyopathy [10], 
neuronal toxicity [11] and radiation damage [12]. Whether CeO2 nanoparticles may exhibit toxic 
effects is not well understood. In vitro studies using the human bronchoalveolar carcinoma cell 
line (A549) and lung epithelial cell lines (BEAS2B) has demonstrated that CeO2 nanoparticles 
(20nm) can reduce cell viability and induce oxidative stress [15]. In vivo studies using male 
Sprague-Dawley rats has shown that the intratracheal instillation of CeO2 nanoparticles (20nm) 
can cause oxidative stress and apoptosis in pulmonary tissues [17]. Using this same model, 
Nalabotu and colleagues have shown that intratracheally instilled CeO2 nanoparticles can travel 
from the lungs and cause liver toxicity in a dose-dependent fashion [121].  
Similarly, other work has shown that inhaled nanoparticles such as silver, silica, copper, 
gold, TiO2 and Zinc oxide nanoparticles can enter into the circulation and cause and apoptosis in 
the liver [116, 117, 155, 156]. It is thought that nanoparticle exposure is associated with 
increased production of ROS [53]. ROS generation is linked to membrane damage and cellular 
apoptosis and is also known to activate the mitogen activated protein kinase (MAPK) pathways 
which are important mediators of cell survival, differentiation and apoptosis [157]. Whether the 
intratracheal instillation of CeO2 nanoparticles can cause increased oxidative stress and 
apoptosis in the liver is currently unclear.  
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 The purpose of this investigation was to evaluate if the hepatic toxicity induced by CeO2 
nanoparticles is associated with activation of oxidative stress and apoptotic protein signaling in 
the liver. We hypothesized that bioaccumulation of cerium in the liver will be associated with 
generation of ROS that will cause damage to cells and that the oxidative stress induced by CeO2 
nanoparticles will activate apoptotic protein signaling in the liver. Taken together, our data 
suggest that intratracheal instillation of CeO2 nanoparticles is associated with accumulation of 
cerium in the liver and the cerium can cause biphasic oxidative stress and apoptotic response in 
the liver. 
 
Materials and Methods 
Particle characterization  
CeO2 nanoparticles, 10 wt % in water (average diameter at ~20 nm), were obtained from 
Sigma-Aldrich (St Louis, MO, USA) as previously outlined [17]. Normal saline was used as vehicle 
to suspend the nanoparticles prior to instillation. Diluted particle suspensions were filtered, 
sputter coated, and examined with a Hitachi Model S-4800 Field Emission scanning electron 
microscope (Schaumburg, IL, USA) at 5 and 20 kV or placed on a formvar-coated copper grid to 
dry and imaged with a JEOL 1220 transmission electron microscope (Tokyo, Japan).  
 
Animal handling, CeO2 nanoparticles instillation and tissue collection 
All procedures were performed in accordance with the Marshall University Animal Care 
and Use Committee guidelines, using the criteria outlined by the Assessment and Accreditation 
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of Laboratory Animal Care (AAALAC). Five week old (150-174 g) Specific pathogen-free male 
Sprague-Dawley (Hla: SD-CVF) rats were purchased from Hilltop Lab Animals, Inc. (Scottdale, 
PA, USA). Rats were housed two per cage in an AAALAC approved vivarium with a 12-h light–
dark cycle. Housing temperature was maintained at 22 ± 2° C and the animals were given access 
to food and water ad libitum. All animals were allowed to acclimatize for 2 weeks before 
initiation of any treatment or procedures. All animals were examined for precipitous weight 
loss, failure to thrive or unexpected gait. Periodic weight measurements were taken throughout 
the duration of the study. After acclimatization, animals were divided randomly into 12 groups 
(n=6 per group). Animals underwent instillation with 0.3 ml of saline suspension or saline 
suspension containing CeO2 nanoparticles as described previously [17]. Rats were euthanized 
with a combination of xylazine and ketamine and livers were collected at 1, 3, 14, 28, 56 or 90 
days post exposure to either the CeO2 nanoparticles or normal saline. After removal from the 
animals, livers were cleaned of blood and connective tissues, weighed, and immediately snap 
frozen in liquid nitrogen. 
 
Determination of cerium content in the liver 
Liver cerium content was estimated for the 1, 28, 56, and 90 day animals by induction 
coupled plasma-mass spectrometry (ICP-MS) at Elemental Analysis Inc. (Lexington, KY, USA) 
using EPA Method 3050B using methods identical to that detailed previously[158]. All Ce-140 
calibration standards were prepared using a certified reference standard traceable to NIST 
reference materials. A continuing calibration verification standard and a continuing calibration 
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blank were analyzed at the beginning of the run, after every ten samples, and at the conclusion 
of the run.  
 
Transmission electron microscopy (TEM) 
 
Liver slices from 90 days control and 90 days post exposure are fixed in Karnovsky’s 
fixative (2.5% glutaraldehyde, 3.5% paraformaldehyde in 0.1 M Sodium Cacodylate buffer), then 
embedded in 4% agarose and refixed for 2 h. The samples were post-fixed in 1% osmium 
tetroxide (120 min at 4C), mordanted in 1% tannic acid (pH 7.0) and block stained in 0.5% 
uranyl acetate (both at room temperature for 60 minutes) all in a buffer of 8%sucrose and 0.9% 
sodium chloride. When the staining was complete, the solution was changed to 70% ethyl 
alcohol and then 90%, samples were then rinsed twice with 100% ethyl alcohol for 15 min each. 
Then placed into a solution of 1:1 100% ethyl alcohol to propylene oxide for 15 min, and finally 
into 100% propylene oxide changing the solution twice. The sample solution was replaced with 
a 1:1 of propylene oxide and LX112 embedding media, followed by a 3:1 solution for 30 min, 
and then finally into 100% solution of LX112 overnight on a rotating platform. This solution was 
changed again for an additional 4 h, then placed into embedding molds and placed into a 60C 
oven for 48 h. Thick (0.5 µm) sections were cut and stained with a 1% toluidine blue (in 1% 
sodium borate) solution on a hot plate for 90 sec. Thin sections (70 nm) were placed on 200 
mesh copper grids and stained with 4% aqueous uranyl acetate and Reynold’s lead citrate for 
15 and 20 min, respectively. Images were taken on a JEOL 1220 transmission electron 
microscope at 80 kV. 
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Lipid peroxidation assay 
Lipid peroxidation assays were performed on liver tissues removed from the 1, 3, 14, 28, 
56 and day 90 exposure animals and compared with the saline controls from each group. 
Briefly, individual liver pieces (200 mg) were homogenized in 1 ml phosphate buffered saline 
and the homogenizer probe then rinsed with an additional 1ml of PBS. Lipid peroxidation was 
measured as described previously [159]. The amount of malondialdehyde (MDA) was calculated 
based on a standard curve (range 1–40 nmol) using MDA (Aldrich, St. Louis, MO) and expressed 
as nmol MDA/g liver tissue. 
 
Dihydroethidium staining 
Liver tissues were serially sectioned (8 µm) using an IEC Microtome cryostat and the 
sections were collected on poly-lysine coated slides. The fluorescent superoxide indicator 
dihydroethidium (HE) was used to evaluate superoxide levels as detailed previously [98]. Upon 
oxidation, dihydroethidium intercalates with DNA exhibiting a bright fluorescent red. Briefly, 
frozen tissue sections were washed with phosphate-buffered saline (PBS) for 5 min and then 
incubated with 200 µl of 10 µM dihydroethidium (Molecular Probes, Eugene, OR, USA) for 1 h 
at room temperature. After washing with PBS (3 X 10 min), fluorescence was visualized under 
Texas red filter using an Olympus BX51 microscope (Olympus America, Melville, NY, USA) 
equipped with Olympus WH 209 wide field eyepieces and an Olympus UPlanF1 409/0.75 
objective lens. 
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TUNEL staining 
Liver tissues were serially sectioned (8 µm) using an IEC Microtome cryostat and the 
sections were collected on poly-lysine coated slides. DNA fragmentation was determined by 
TdT-mediated dUTP nick end labeling (TUNEL) according to the manufacturer’s 
recommendations (In Situ Cell Death Detection Kit, Roche Diagnostics, Mannheim, Germany). 
TUNEL staining was performed on tissue sections obtained from saline controls and the day 1, 
3, and 90 CeO2 nanoparticle exposure groups (n=4/group) as described elsewhere [98]. Cross-
sections from each tissue were treated with DNase-I to induce DNA fragmentation as a positive 
control. Liver sections were blocked with 3% BSA and incubated with anti-dystrophin antibody 
(NCL-DYS2, Novocastra Vector Laboratories, Burlingame, CA, USA) at a dilution of 1:200 to 
visualize the cell membrane. Nuclei were counter stained using DAPI (Vectashield HardSet 
Mounting Medium, Vector Laboratories, Burlingame, CA, USA). Liver cross sections were 
visualized by epifluorescence using an Olympus fluorescence microscope (Melville, NY, USA) 
fitted with 20X and 40X objectives and the images recorded digitally using a CCD camera 
(Olympus, Melville, NY, USA). The number of TUNEL positive nuclei was counted in three 
randomly selected regions in each slide. Four different animals were counted from each group. 
 
Immunoblotting analysis  
Portions of individual liver tissues (100-150mg) were homogenized in buffer (T-PER, 8 
mL/g tissue; Pierce, Rockford, IL, USA) containing protease (P8340, Sigma-Aldrich, Inc., St. Louis, 
MO, USA) and phosphatase inhibitors (P5726, Sigma-Aldrich, Inc., St. Louis, MO, USA) and 
sonicated (3 x 30 sec at 150W). The supernatant protein was collected by centrifuging the 
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tissue homogenate at 12,000g for 5 minutes at 4°C. Protein concentration of homogenates was 
determined via the 660nm assay method (Fisher Scientific, Rockford, IL, USA). After boiling in 
Laemmli 2X sample buffer (Sigma-Aldrich, Inc., St. Louis, MO, USA) for 5 min, 32µg of total 
protein for each sample was separated on a 10% PAGEr Gold Precast gel (Lonza, Rockland, ME, 
USA) and then transferred to nitrocellulose membranes. Gels were stained with a RAPID Stain 
protein stain reagent (G-Biosciences, St. Louis, MO, USA) to verify transfer efficiency to 
membrane. Membranes were stained with Ponceau S and the amount of protein quantified by 
densitometric analysis to confirm successful transfer of proteins and equal loading of lanes as 
detailed somewhere else [120]. Membranes were blocked with 5% milk in Tris Buffered Saline 
(TBS) containing 0.05% Tween-20 (TBST) for 1 h and then incubated with primary antibody 
overnight at 4°C. After washing with TBST, the membranes were incubated with the 
corresponding secondary antibodies conjugated with horseradish peroxidase (HRP) (anti-rabbit 
(#7074) or anti-mouse (#7076), (Cell Signaling Technology, Danvers, MA, USA) for 1 h at room 
temperature. Protein bands were visualized following reaction with ECL reagent (Amersham 
ECL Western Blotting reagent RPN 2106, GE Healthcare Bio-Sciences Corp., Piscataway, NJ, 
USA). Target protein levels were quantified by AlphaView image analysis software (Alpha 
Innotech, San Leandro, CA, USA). Protein levels were normalized with the corresponding 
GAPDH protein level and expressed as increased expression when compared with the controls. 
Primary antibodies against caspase-3 (#9662), cleaved caspase-3 (#9661S), Bax (#2772), Bcl-2 
(#2870S), caspase-9 (#9506), nuclear factor-kappa  p65 (#3034) , Phosho NF-k P65 (Ser536 # 
3033), p38 MAPK (#9212), Phospho p38 MAPK (Thr180/Tyr182) (#9216L) were purchased from 
Cell Signaling  Technology (Beverly, MA, USA). 
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Multiplexed serum protein immunoassays 
Pooled serum samples from all six animals in the 1-, 3-, 28-, 56- and 90-day 
experimental groups were shipped on dry ice to Rules Based Medicine (Austin, Texas) for 
Rodent MAP® version 2.0 Antigen analysis using a Luminex 100 instrument as detailed 
elsewhere [121]. The antigen panel consisted of fifty-nine proteins, which included proteins 
involved in inflammation, cytokines, growth factors and tissue factors. Each analyte was 
quantified using 4 and 5 parameter, weighted and non-weighted curve fitting algorithms using 
proprietary data analysis software developed at Rules-Based Medicine. 
 
Data Analysis 
Results are presented as mean ± SEM. Data were analyzed using the Sigma Plot 11.0 
statistical program. One-way analysis of variance and two-way analysis of variance were 
performed for overall comparisons, while the Student–Newman–Keuls post hoc test used to 
determine differences between groups. Values of P<0.05 were considered to be statistically 
significant. 
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Results 
Nanoparticle characterization 
Similar to previous work [17, 121] which used the same batch of CeO2 nanoparticles, 
TEM and scanning electron microscopy confirmed the presence of single and agglomerated 
CeO2 nanoparticles in the suspensions. Field emission scanning electron microscopy showed 
that the CeO2 nanoparticles were generally dispersed into submicron groups with an average 
size of 9.26 ± 0.58 nm. The diameter of the primary CeO2 particles was determined to be 10.14 
± 0.76 nm by TEM. 
 
Effect of CeO2 nanoparticle exposure on feed intake, body weight gain and liver ceria levels  
CeO2 nanoparticle exposure had no effect on the average food intake or weight gain 
(Figure 3.17). Compared to saline control animals, CeO2 nanoparticle exposure did not increase 
the liver weight to body weight ratio (Table 5). Compared to the day 1 exposure animals, the 
liver weight to body weight ratio was reduced in the day 3, 28, 56, and 90 day animals (Table 5). 
The concentration of cerium was undetectable in the saline control animals (Figure 3.18). The 
concentration of the cerium at day 1 post exposure was 0.03 ± 0.01 ppm and increased 
thereafter before peaking at 0.20 ± 0.04 ppm at day 90 (P<0.001). However, total cerium 
content in the liver also appears to increase with the progression of the days of exposure (Data 
not shown).  
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Alterations in the ultrastructure of hepatocytes 
TEM image of the liver shows that the sub-µm sized nanoparticles are dispersed in the 
hepatocytes (Figure 3.19 a and b). Alterations observed in the ultrastructure of the liver with 90 
days post CeO2 nanoparticles exposure include reduced fat droplets when compared with the 
90 days control animals, increased non-specific deposition of particulate material in the 
hepatocytes, altered mitochondrial structure and increased number of peroxisomes or 
lysosomes and splitting of endoplasmic reticulum. 
 
CeO2 nanoparticle exposure is associated with lipid peroxidation, elevations in hepatic 
superoxide levels and evidence of hepatic apoptosis. 
Compared to age matched control animals, the concentration of MDA per gram of the 
liver tissue was elevated by 25%, 31%, and 20% at day 1, 3, and 90, respectively (P<0.05) (Figure 
3.20). Similarly, compared to control animals, dihydroethidium fluorescence intensity was 
increased by 122%, 145%, and 96% at days 1, 3, and 90, respectively (P<0.05) (Figure 3.21). 
Compared to day 1 saline controls, CeO2 nanoparticle exposure increased the number of TUNEL 
positive nuclei by 378%, 351% and 435% at days 1, 3 and day 90 post exposure (Figure 3.22). 
 
Apoptosis induced by CeO2 nanoparticles is associated with caspase cleavage  
Compared to day 1 saline controls, the Bax to Bcl-2 protein ratio was 32% and 10% 
higher in the day 1 and 3 exposure groups (P<0.05). After day 3, the Bax to Bcl-2 ratio began to 
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decline and was 55%, 62%, and 47% lower in the day 14, 28 and 56 exposure animals (P<0.05) 
(Figure 3.23). 
Caspases are cysteine-dependent aspartate specific proteases that are activated during 
cell death. Compared to saline control day 1 animals, caspase-9 protein levels in CeO2 
nanoparticle exposed animals were 25%, 21% and 35% higher at days 1, 3, and 90 exposure, 
respectively (P<0.05). In a similar fashion, the amount of cleaved caspase-9 (activated) was 
29%, 36% and 60% higher in the day 1, 3 and 90 animals, respectively (P<0.05) (Figure 3.24). 
Compared to saline control day 1, caspase 3 levels were 16% higher in day 1 exposure group 
(P<0.05). Compared to saline control day1, the amount of cleaved caspase-3 (activated) was 
32%, 49% and 13% higher in the day 1, 3 and 90 exposure groups (P<0.05) (Figure 3.25). 
 
CeO2 nanoparticle exposure affects p38 MAPK and NF-K phosphorylation in the liver 
Compared to saline control day1, the ratio of phosphorylated p38 MAPK to total p38 
MAPK ratio was reduced by 7%, 16%, and 50% in the day 1, 3, and 90 exposure animals 
(P<0.05). Conversely, the ratio of phosphorylated p38 MAPK (Thr180/Tyr 182) to total p38 
MAPK ratio was elevated by 100%, 65%, and 91% in the day 14, 28 and 56 exposure groups 
(P<0.05) (Figure 3.26). Similar to p38 MAPK, it is thought that the NF-k p65 plays a protective 
role in the liver [160-162]. Compared to saline control day 1 animals, the ratio of 
phosphorylated NF-k p65 (Ser536) to total NF-k p65 protein was reduced by 14%, 5%, and 
67% in the day 1, 3, and 90 exposure groups (P<0.05). Compared to saline control day 1 
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animals, phosphorylated NF-k p65 to total NF-k p65 protein levels were 26%, 34%, and 18% 
higher for day 14, 28 and 56 exposure groups (P<0.05) (Figure 3.27). 
 
CeO2 nanoparticle exposure alters serum inflammatory biomarkers 
We monitored 55 serum biomarkers that include inflammatory cytokines, interleukins, 
chemokines, tissue factors and growth factors. Among the 55 parameters, 35 showed changes 
in the expression across all the groups. Compared to saline control day 1 animals, CeO2 
nanoparticle exposure increased the expression of 26 parameters, lowered expression of 8 
parameters and failed to change the expression for one parameter (Figure 3.28 a). Compared to 
saline control day 1 animals, the 3 day exposure group showed an elevation of expression for 8 
parameters, lowered expression for 22 parameters and no change in the expression of 5 
parameters (Figure 3.28 b). Compared to saline control day 1 animals, animals in the day 28 
exposure group showed an elevation of 10 parameters, lowered expression for 19 parameters 
and no change in the expression of 6 parameters (Figure 3.28 c). Compared to saline control 
day 1, the day 90 exposure group showed an elevation of 5 parameters, a lowered expression 
for 24 parameters and no change in the expression for 6 parameters (Figure 3.28 d). 
 
Discussion 
Previous investigations examining the toxicity of metallic nanoparticles have 
demonstrated that the exposure to silver, gold, silica, copper, zinc oxide and TiO2 nanoparticles 
increases hepatic ROS and cell apoptosis [116, 117, 155, 156]. We found evidence of a similar 
phenomenon in the liver following the instillation of CeO2 nanoparticles.  Specifically, our 
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primary finding was that the deposition of ceria in the liver is associated with evidence of 
increased tissue ROS and cellular apoptosis.  
One potential marker of increased oxidative stress is lipid peroxidation[163]. Lipid 
peroxidation is the end product of the oxidative degradation of lipids and can be assessed by 
the measurement of malondialdehyde (MDA) levels [163]. Here we observed that ceria 
deposition in the liver was associated with elevations in the amount of liver MDA at 1, 3 and 90 
days after exposure (Figure 3.20). Interestingly, there was no evidence of elevated MDA levels 
at days 14, 28, or 56 of exposure. In addition to MDA levels, we also examined liver tissue 
sections for the presence of superoxide using dihydroethidium staining (Figure 3.21). Consistent 
with our MDA data, the HE staining procedure demonstrated that CeO2 instillation at a dose of 
7.0 mg/kg was associated with a robust increase in liver superoxide levels at day 1, 3 and 90 of 
exposure (Figure 3.22). Taken together, these data demonstrated that CeO2 nanoparticles can 
induce the generation of ROS [164, 165] and in addition, that increases in hepatic ROS levels 
appear to be associated with increased hepatocyte lipid peroxidation. Why MDA and 
superoxide levels are increased at the early (days 1 and 3) and late (day 90) but not the middle 
time points is not clear. We suspect that the acute exposure to large dose of nanoparticles seen 
during the initial phase of the study is associated with the development of a systemic 
inflammatory response and increased oxidative stress which is then followed by a “remodeling 
phase”. During this remodeling phase, ceria deposition continues in the liver which reaches a 
maximal level at day 90 (Figure 3.18) at which point the ceria levels may be high enough to 
initiate a second wave of inflammation and cell death. It is also observed that with the 
increased deposition of the CeO2 nanoparticles in the hepatocytes as seen from the TEM 
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images of the liver, there are increased alterations in the structure of the organelles such as 
mitochondria and endoplasmic reticulum (Figure 3.19). More research, perhaps using 
additional time points longer than 90 days post exposure will be needed to mechanistically 
define the biphasic inflammatory response we observed in the liver.  
To evaluate if the oxidative stress at days 1, 3 and 90 exposure groups was associated 
with the hepatocyte apoptosis, we next performed TUNEL staining to examine hepatocytes for 
the presence of double stranded DNA breaks. As predicted, our TUNEL analysis was consistent 
with the possibility of increased liver apoptosis at these time points (Figure 3.22). In an effort to 
better understand the potential mechanism(s) underlying these findings we next prepared 
protein isolates from the liver and used immunoblotting to examine the isolates for changes in 
apoptotic signaling. Immunoblotting was conducted on day 1 control isolates, and protein 
fractions from animals that had been exposed to the cerium oxide nanoparticles for 1, 3, 14, 28, 
56, or 90 days. Our findings suggested that there was increased proapoptotic Bax/Bcl-2 protein 
signaling at day 1 and 3 post exposure that decreased thereafter. Proapoptotic protein signaling 
appeared to be diminished at day 14, 28, and 56 post exposure. Interestingly, and consistent 
with our oxidative stress data, we noted a robust increase in proapoptotic protein signaling in 
90 day exposure group when compared to what was observed in the 56 day exposure animals 
(Figure 3.23).  
Given that increases in the ratio of Bax/Bcl-2 can give rise to cellular apoptosis via the 
activation of intracellular caspases, we next examined our protein isolates for evidence of 
caspase cleavage. Our data suggested that there were increased levels of active caspase-9 
(cleaved caspase-9) at day 1, 3, and day 90 post exposures (Figure 3.24). Conversely, the 
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expression of active caspase 9 appeared to be declined in the day 14, 28 and 56 exposure 
animals. Similar to our findings for Bax/Bcl-2 we also noted an increase in the amount of 
cleaved caspase-9 in the day 90 exposure group (Figure 3.24). To extend these findings, we 
repeated these experiments and examined if caspase-3 exhibited a similar trend. Like our data 
for caspase-9, caspase-3 cleavage also appeared to be increased at days 1, 3, and 90 (Figure 
3.25). Taken together, these data, when considered in the context of our TUNEL findings, 
suggest that ceria deposition in the liver is associated with hepatic apoptosis and that these 
findings may be mediated by increased levels of oxidative stress. Why the apoptotic response 
appears to be biphasic in nature is not currently clear.   
The p38 MAPK and NF-k-P65 are thought to play important roles in the protection of 
the liver from oxidative stress and apoptosis [160, 161, 166, 167]. When phosphorylated, p38 
MAPK, and NF-k-P65 activate a number of different transcription factors which can then travel 
to the nucleus to induce changes in gene expression [161, 166]. Phosphorylated p38 MAPK has 
been shown to be involved in reducing the production of inflammatory factors [162, 168]. In 
the current study, we found that the ratio of phosphorylated to total p38 MAPK protein level 
was unaltered at days 1 and 3 post exposure while it was increased at days 14, 28, and 56 post 
exposure (Figure 3.26). Consistent with these findings, we also found that p38 MAPK activation 
(phosphorylation) appeared to be significantly reduced in the day 90 exposure group. Like p38 
MAPK, the NF-k P65 is also thought to play a crucial role in hepatic cell survival and 
proliferation [160, 161]. Similar to our findings for p38 MAPK, we observed that the ratio of 
phosphorylated to total NF-k P65 protein levels appeared to be reduced in the day 1 and 3 
exposure groups, elevated in the day 14, 28, and 56 before becoming significantly reduced in 
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the day 90 animals (Figure 3.27). Whether these decreases in p38 MAPK and NF-k activation 
can explain the increased susceptibility of the liver to exhibit increased oxidative stress and 
cellular apoptosis at day 90 post exposure is currently unclear and will require further 
investigation.  
In addition to examining the effects of ceria deposition on the liver we also examined if 
exposure to CeO2 nanoparticles elicited changes in proinflammatory cytokines. Our analysis of 
serum biomarkers suggested that CeO2 nanoparticle exposure was associated with increased 
levels of cytokines, tissue factors and growth factors. In particular, our data suggested that ceria 
deposition in the liver was characterized by elevated acute phase reactant proteins such as  
fibrinogen, haptoglobin, serum amyloid P-component and Von Willebrand’s factor at days 1, 3, 
28, 56, and 90 [121, 152] (Figure 3.28). Our analysis of the serum also suggested that inhalation 
of CeO2 nanoparticles was also associated with an allergic response. Eotaxin is a chemokine that 
attracts eosinophils to the site of injury to elicit an inflammatory response [169]. MCP-1, MCP-
3, MIP-1 beta and MIP-2 are a group of chemokines that are induced by eotaxin, and have been 
shown to play a crucial role in the inflammation induced by eosinophils [170-172]. In addition, 
eotaxin also exhibits the ability to selectively prime eosinophils for chemotaxis, to direct their 
migration/chemotaxis, and to activate inflammatory activity in the cells attracted [171-173]. 
Two cell types that are candidates for mediating such an early or initial response are mast cells, 
a known source of IL-4 and TNF-alpha a finding which is consistent with our observation of 
increased IL-4 following CeO2 nanoparticle exposure [171, 173].  
Taken together, the data of the current study demonstrate that the exposure to CeO2 
nanoparticles is characterized by acute increases in hepatic oxidative stress, elevations in 
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hepatic apoptosis, and an eosinophil mediated inflammatory response that declines over time.  
Interestingly, at day 90 post exposure, oxidative stress and apoptosis once again increases. 
Although unable to demonstrate cause and effect, the increased oxidative stress and apoptosis 
at day 90 appears to be correlated with the increased bioaccumulation of cerium in the liver as 
well as diminished p38 MAPK and NF-kB activation. Further studies may be warranted to 
determine if exposure to CeO2 nanoparticles is associated with any long term effects on hepatic 
structure and function.     
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Figure 3-17: Intratracheal instillation of CeO2 nanoparticles does not alter feed intake and body 
weight gain  
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Table 5: Alterations in the liver weight, body weight and coefficient of liver weights with the 
ceO2 nanoparticle exposure 
 
 
*Significant difference from the 1 Day exposure group in each condition 
α Significant difference from the 3 Day exposure group in each condition 
μ Significant difference from the 14 Day exposure group in each condition 
¶ Significant difference from the 28days exposure group 
# Significant difference from the 56days exposure group 
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Figure 3-18: Accumulation of cerium in the liver with the days of the exposure to CeO2 
nanoparticles  
 
 
 
* Significant difference from control-1 
¶ Significant difference from Day-1 exposure 
α Significant difference from Day-28 exposure 
# Significant difference from Day-56 exposure 
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Figure 3-19: Alterations in the ultrastructure of the hepatocytes as observed with TEM a) 90 
days control, b) 90 days CeO2 nanoparticles exposed liver 
 
Black Arrow: Deposition of CeO2 nanoparticles 
Red Arrow: Altered mitochondrial structure with CeO2 nanoparticle exposure 
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Figure 3-20: CeO2 nanoparticles can cause lipid peroxidation of the hepatic cell membranes  
 
 
 
 
* Significant difference from the controls in each group 
¶ Significant difference from the 14, 28 and 56 days CeO2 exposure group 
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Figure 3-21:  Increased generation of superoxide radicals in the liver with the intratracheal 
instillation of CeO2 nanoparticles 
 
 
* Significant difference from control-1 
¶ Significant difference from Day-1 exposure 
# Significant difference from Day-3 exposure 
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Figure 3-22: CeO2 nanoparticles exposure can increase TUNEL positive nuclei in the liver 
 
 
 
* Significant difference from control-1 
¶ Significant difference from Day-3 exposure 
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Figure 3-23: Activation of proapoptotic protein signaling in the liver following intratracheal 
instillation of CeO2 nanoparticles. 
Protein bands of the Bax and Bcl-2 proteins and corresponding GAPDH are represented in the 
figure. Bands corresponding to the X-axis labels are shown in the immunoblotting images. 
Protein levels were adjusted by GAPDH levels and compared with the control day-1. 
 
 
* Significant difference from control-1 
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Figure 3-24: CeO2 nanoparticle exposure can activate initiator caspase-9  
Protein bands of the Caspase-9 and cleaved caspase-9 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 
* Significant difference from control-1 
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Figure 3-25: CeO2 nanoparticle exposure can activate executor caspase-3  
Protein bands of the Caspase-3 and cleaved caspase-3 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1.  
 
 
 
* Significant difference from day 1 control animals 
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Figure 3-26: CeO2 nanoparticle exposure can alter the cell protective signaling in the liver by 
modulating the activity of p38 MAPK 
Protein bands of the p38 MAPK and phospho p38 MAPK proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 
* Significant difference from day 1 control animals 
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Figure 3-27: CeO2 nanoparticle exposure can alter the cell protective signaling in the liver by 
modulating the activity of NF-k activity 
Protein bands of the NF-k and phospho NF-k p65 proteins and corresponding GAPDH are 
represented in the figure. Bands corresponding to the X-axis labels are shown in the 
immunoblotting images. Protein levels were adjusted by GAPDH levels and compared with the 
control day-1. 
 
 
 
* Significant difference from day 1 control animals 
 
 
 
 
 
 
 
 
 
112 
 
Figure 3-28: Intratracheal instillation of CeO2 nanoparticles can alter the expression of serum 
biomarkers that play an important role in the inflammation and/ or act as inflammatory 
cytokines and tissue factors 
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Chapter 4  
 
General Discussion 
The applications of nanotechnology are growing tremendously in several sectors 
including electronics (chips, screens), energy (production, catalysis, and storage), materials 
(lubricants, abrasives, paints, tires and sportswear), consumer products (clothes, goggles, skin 
lotions and sun screens), automotive, soil/water remediation (pollution absorption, water 
filtering, and disinfection), pesticides, chemicals and pharmaceutical industries [1, 2, 30, 39, 40]. 
It is estimated that there are almost 800 nanoproducts currently available [5]. With increased 
production and utilization of nanomaterials, there is increased chance of exposure to 
nanomaterials. The primary goal of this study was to investigate the potential toxic effects 
induced by CeO2 nanoparticles following intratracheal instillation.  
CeO2 nanoparticles have application in fuel cells, solid cells, the polishing industries and 
biomedical fields [7]. Potential sources of CeO2 nanoparticles exposure to the humans include 
environmental and industrial sources. While inhalation is the most common route of exposure, 
ingestion is also possible. But the inhalation route of exposure is the route of exposure of most 
concern as the absorption through oral route is very minimal [7].  
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CeO2 nanoparticles induced oxidative stress and apoptosis in the lungs is associated with 
MAPK and caspase activation  
CeO2 nanoparticles have been shown to induce oxidative stress and apoptosis in 
cultured lung cells[16]. However, little is known about the effects of these nanomaterials on the 
intact lung. In addition, the cell signaling events associated with the CeO2 nanoparticle toxicity 
are not currently clear. Here we evaluated the role of MAPKs and caspases in the oxidative 
stress and apoptosis induced by CeO2 nanoparticles in the lungs following intratracheal 
instillation. Similar to previous work [119], CeO2 nanoparticle exposure is associated with the 
activation of MAPKs protein signaling and increased oxidative stress. Specifically, we observed 
that CeO2 nanoparticles activate p38 MAPK and inhibit the activity of ERK 1/2-MAPK. In 
addition, our data also show that the p38 MAPK activation (phosphorylation) is paralleled by 
STAT-3 phosphorylation. Phosphorylated p38 MAPK has been shown to play an important role 
in the activation of inflammatory cell signaling pathway by activating different cell signaling 
events and STAT-3 protein signaling is one such pathway [174]. CeO2 nanoparticle exposure is 
also associated with an elevation of serum biomarkers that have been shown to play very 
crucial roles as inflammatory mediators. Increased oxidative stress is associated with increased 
protein expression of proapoptotic Bax and reduced expression of anti-apoptotic Bcl-2. This 
proapoptotic protein signaling is associated with the activation of caspase-9 and caspase-3. 
Altogether, the data from the current study indicates that CeO2 nanoparticle induced oxidative 
stress is mediated through activation of the stress responsive MAP kinase protein signaling 
pathway, phosphorylation of STAT-3 and activation of the intrinsic pathway of apoptosis.   
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CeO2 nanoparticles produce toxic effects in the liver 
Our next step was to examine if CeO2 nanoparticles could translocate to other organs 
from the lungs through the circulation. For these experiments, we evaluated the 
histopathology, organ weights and cerium concentration in the liver, kidney, spleen and heart. 
Similar to that observed with other nanoparticles [26, 27], CeO2 nanoparticle exposure was 
associated with increased liver ceria levels, elevations in serum alanine transaminase levels, 
reduced albumin levels, a diminished sodium-potassium ratio and decreased serum triglyceride 
levels. Consistent with these data, rats exposed to CeO2 nanoparticles also exhibited reductions 
in liver weight and dose dependent hydropic degeneration, hepatocyte enlargement, sinusoidal 
dilatation and the accumulation of granular material in the hepatocytes. No histopathological 
alterations were observed in the kidney, spleen and heart. Analysis of the serum biomarkers 
suggested that there was an elevation of the acute phase reactants in the CeO2 nanoparticles 
exposed rats. Taken together, these data suggest that intratracheal instillation of CeO2 
nanoparticles can result in liver accumulation and can damage the liver. 
 
Hepatic toxicity induced by CeO2 nanoparticles is associated with oxidative stress and 
apoptosis  
There are several studies that show that nanoparticle toxicity is mediated through the 
activation of oxidative stress and apoptosis [2, 24]. To investigate this mechanism, rats were 
instilled with either CeO2 nanoparticles or normal saline and sacrificed 1, 3, 14, 28, 56 or 90 
days after exposure. Our data demonstrated an increase in the concentration of cerium with 
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day of the exposure indicating that cerium bioaccumulates in the liver.  Lipid peroxidation 
assays and staining with dihydroethidium indicated increased oxidative stress 1, 3 and 90 days 
post exposure. Compared to saline control animals, the increased oxidative stress was 
associated with evidence of apoptosis in the livers at 1, 3 and 90 days exposure groups. 
Immunoblotting data indicated that these changes were associated with an increased 
proapoptotic Bax/Bcl-2 ratio, increased caspase-9 protein levels and increased caspase-3 
protein levels. Taken together, these data suggest that CeO2 nanoparticle exposure is 
associated with increased oxidative stress and apoptosis in the liver.  
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Summary 
1. Intratracheal instillation of CeO2 nanoparticles is associated with changes in the 
histological and gross appearance of the lungs. 
2. CeO2 nanoparticle instillation is associated with activation of MAP kinase and STAT-3 
signaling in the lungs.  
3. CeO2 nanoparticle instillation is associated with oxidative stress in the lungs and 
activation of intrinsic pathway of apoptosis. 
4. The CeO2 nanoparticles can translocate to the liver and induce toxic effects on the liver 
but do not appear to induce any histological alterations in the kidney, spleen or heart. 
5. Histological alterations induced by CeO2 nanoparticles include hydropic degeneration, 
hepatocyte enlargement, sinusoidal dilatation and the accumulation of granular 
material inside the hepatocytes. 
6. CeO2 nanoparticles appear to bioaccumulate in the liver. 
7. CeO2 nanoparticle induced hepatic toxicity is associated with oxidative stress and 
apoptosis. The oxidative stress and apoptosis appear to follow a biphasic response. 
8. CeO2 nanoparticles exposure causes the generation of ROS and apoptosis of the 
hepatocytes. CeO2 nanoparticles also appear to cause lipid peroxidation of the 
membranes.  
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Figure 4-1:  Activation of MAP kinases and caspases in the lungs 
 
 
Note: In the above figure, black colored text indicates the results from our studies and the red 
colored text indicates what is already known or what can be implied from the previous studies. 
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Figure 4-2: Possible route of translocation of CeO2 nanoparticles into the liver 
 
Note: In the above figure, black colored text indicates the results from our studies and the red 
colored text indicates what is already known or what can be implied from the previous studies. 
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Figure 4-3: Possible role of oxidative stress and apoptosis in the hepatic toxicity induced by 
CeO2 nanoparticles 
 
Note: In the above figure, black colored text indicates the results from our studies and the red 
colored text indicates what is already known or what can be implied from the previous studies. 
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Future Directions 
The current study evaluated the role of the oxidative stress and apoptosis in the toxicity 
induced by CeO2 nanoparticles in the lungs and liver. We have shown that the CeO2 
nanoparticles can be translocated from the lungs to the liver and have shown that these 
materials induce oxidative stress and apoptosis. Previous work by others has shown that 
nanoparticles can be localized to subcellular organelles [21-23, 70]. Future work could 
determine if the mitochondria and nucleus take up CeO2 nanoparticles. Although we have 
shown that CeO2 nanoparticles can accumulate in the liver, it is not clear if they can be taken up 
by other organs or not. Additional studies examining other tissues or organs are needed. 
Potential aims for future studies could be:  
 
Specific Aim I 
To investigate the possible subcellular localization of the CeO2 nanoparticles in the 
mitochondria and nucleus as well as to investigate the possible structural and functional 
alterations induced by CeO2 nanoparticles following subcellular localization. Electron 
microscopy could be used to examine the structural alterations as well as the subcellular 
localization. Mitochondria or nuclei could be isolated to examine changes in protein 
signaling or for evidence of DNA damage.  Mitochondrial function could be assessed by 
measuring the rate of mitochondrial ATP production and mitochondrial oxygen 
consumption using assay kits. 
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Specific Aim II:  
To investigate the possible toxic effects of CeO2 nanoparticles on the other vital organs 
such as brain. Studies have shown that the nanoparticles can enter brain and disturb the 
blood-brain barrier [1, 6, 96]. It is not clear if CeO2 nanoparticles can induce any damage 
to the brain. We could investigate if cerium can accumulate in the brain and induce any 
structural alterations in the brain. We could also investigate if oxidative stress, 
inflammation and apoptosis have any role in the CeO2 nanoparticles induced brain 
toxicity.    
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